1990
- AIDS : facts and fears, crisis and controversy. [videorecording]
- [Mt. Kisco, N.Y.] : Guidance Associates, c1986 1 videocassette (57 min.) : sd., col. ; 1/2 in. + 1 guide + 2 handouts Unique Identifier : AIDSLINE AV/9000919A
- Pindyck J
- (Producer) Here s a video that explicitly presents how AIDS is transmitted - stressing the behaviors that put people at risk. Experts present evidence that there is little or no risk of contagion through blood transfusions and casual contact. Medical experts explain the clinical nature of the virus and how it attack
- One of our own. [videorecording]
- Chicago, Ill. : Dartnell Corp., c1987 1 videocassette (30 min.) : sd., col. ; 1/2 in. + 2 guides + 4 handouts + 1 poster Unique Identifier : AIDSLINE AV/9000930A
- (Producer) Since the first cases of AIDS were diagnosed, the fear of AIDS has spread almost as quickly as the disease itself. Even though the virus associated with AIDS is transmitted in only a limited number of identifiable ways, questions have been raised about possible exposure to the disease in the workplace. As
- [Hilfe vor AIDS : der AIDS-Report der Gesellschaft fur Naturheilkunde Deutschland e.V.]
- Munchen : Die Gesellschaft, c1986 94 p Unique Identifier : AIDSLINE CAT/9011179
- Wahler J
- Trends in sexually transmitted diseases in Western Australia, 1974-1987 : with special reference to effects of the AIDS public education campaign.
- Perth : Health Dept. of Western Australia, 1987 i, 29 leaves : ill Unique Identifier : AIDSLINE CAT/9010564
- Roberts M; Holman CD; Machin J
- AIDS and syphilis : the hidden link.
- Berkeley, Calif. : North Atlantic Books ; Washington, D.C. : Wehawken Book Co., c1987 xii, 132 p Unique Identifier : AIDSLINE CAT/9010619
- Coulter HL
- AIDS, the problem in Ireland.
- Dublin : Town House, 1987 141 p Unique Identifier : AIDSLINE CAT/9010621
- Freedman D
- The:AIDS book : information for workers. 3rd rev. ed.
- Calif.). AIDS Education Committee Washington, D.C. : Service Employees International Union (1313 L St., NW, Washington, DC 20005), 1988 96 p Unique Identifier : AIDSLINE CAT/9010312
- Administrator's guide to AIDS education.
- Chicago, Ill. : National Safety Council, c1988 31 p Unique Identifier : AIDSLINE CAT/9010598
- AIDS in Africa : the social and policy impact.
- Lewiston : Edwin Mellen Press, c1988 xxxi, 336 p. : ill (Studies in African health and medicine ; v. 10 [i.e. 1]) Unique Identifier : AIDSLINE CAT/9010620
- Miller NN; Rockwell RC
- Coping with AIDS : the public response to the epidemic.
- Dubuque, Iowa : Kendall/Hunt Pub. Co. ; Dayton, Ohio : National Issues Forms, [c1988] 44 p. : ill (National issues forums) Unique Identifier : AIDSLINE CAT/9010660
- Melville K
- Reports on aids in the African press : an annotated bibliography.
- Bloomington, IN : African Studies Program, Indiana University, [1988] 47 p Unique Identifier : AIDSLINE CAT/9010899
- Schmidt NJ
- Secretary's Work Group on Pediatric HIV Infection and Disease : final report.
- Work Group on Pediatric HIV Infection and Disease [Washington, D.C.] : Dept. of Health and Human Services ; Washington, DC : For sale by the Supt. of Docs., U.S. G.P.O., [1988] 92 p. : ill (NIH publication ; no. 89-3063) Unique Identifier : AIDSLINE CAT/9010908
- AIDS in gastroenterology and hepatology : proceedings of the First International Congress on the Gastrointestinal Tract and the Liver in the Acquired Immunodeficiency Syndrome, Munich, June 9-10, 1988.
- Grafelfing : Demeter Verlag, [1988?] ix, 77 p. : ill Unique Identifier : AIDSLINE CAT/9011051
- Classen M; Dancygier H; Liver in the Acquired Immunodeficiency Syndrome
- HIV infection in the brain.
- [Stockholm] : Dept. of Virology, Karolinska Institute, [1989] 1 v. (various pagings) : ill Unique Identifier : AIDSLINE CAT/9010064
- Chiodi F
- HIV infection : a prospective longitudinal study of clinical, immunological, and virological characteristics of the infection.
- Stockholm : Karolinska institute, 1989 1 v. (various pagings) : ill Unique Identifier : AIDSLINE CAT/9010402
- Morfeldt-Manson L
- AIDS, Africa, and racism. [New and rev. ed.].
- London : Free Association Books, 1989 192 p Unique Identifier : AIDSLINE CAT/9011052
- Chirimuuta RC; Chirimuuta RJ
- Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers : a response to P.L. 100-607, the Health Omnibus Programs Extension Act of 1988.
- Atlanta, Ga. : U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, [1989] 46 p (DHHS (NIOSH) publication ; 89-107) Unique Identifier : AIDSLINE CAT/9011167
- Report.
- Pacific AIDS/HIV Infection Manila, Philippines : Printed and distributed by the Regional Office for the Western Pacific of the World Health Organization, 1989 28 p Unique Identifier : AIDSLINE CAT/9011323
- WorldAIDS. No. 1 (Jan. 1989)-
- London : Panos Institute in association with the Bureau of Hygiene and Tropical Diseases, c1989- v. : ill Unique Identifier : AIDSLINE CAT/9011394
- Economic aspects of AIDS and HIV infection.
- Berlin ; New York : Springer-Verlag, c1990 xvi, 364 p. : ill (Health systems research) Unique Identifier : AIDSLINE CAT/9010017
- Schwefel D; Committee on Health Services Research; (Gesellschaft fur Strahlen- und Umweltforschung)
- Planning for AIDS care.
- Chicago, IL : American Hospital Association, c1990 46 p. : ill Unique Identifier : AIDSLINE CAT/9010506
- Sandrick KM; McGrath DG; Reczynski DF; Neiman JS; and Marketing; and Marketing. Issues and Policy Committee
- AIDS and intravenous drug use : future directions for community-based prevention research.
- Rockville, MD (5600 Fishers Lane, Rockville, 20857) : U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse ; Washington, D.C. : For sale by the Supt. of Docs., U.S. G.P.O., 1990 xiv, 305 p. : ill (NIDA research monograph ; 93) Unique Identifier : AIDSLINE CAT/9011050
- Leukefeld CG; Battjes R; Amsel Z
- Rehabilitation for patients with HIV disease.
- New York : McGraw-Hill, Health Professions Division, c1991 xix, 507 p. : ill., form Unique Identifier : AIDSLINE CAT/9010618
- Mukand J
- TREATMENT OF BURKITT'S AND UNDIFFERENTIATED NON-BURKITT'S LYMPHOMA USING INTENSIFICATION HIGH-DOSE ARA-C AND EXTENDED CONSOLIDATION CHEMOTHERAPY. AN ECOG STUDY (MEETING ABSTRACT)
- Proc Annu Meet Am Soc Clin Oncol; 9:A1010 1990. Unique Identifier : AIDSLINE ICDB/90661789
- Mazza JJ; Hines JD; Anderson JW; O'Connell MJ; Marshfield Clinic, Marshfield, WI 54449
- 73 patients (pts) were entered into a protocol for treatment of Burkitt s and undifferentiated non-Burkitt s lymphoma (EST3484) consisting of induction chemotherapy (CTX 1.2 g/m2 day 1; Oncovin 1.4 mg/m2 days 3, 10, 17 and 24; MTX 300 mg/m2 iv day 12 followed by leucovorin rescue; prednisone 60 mg/m2 po days 3-30 with
- STUDIES ON TRANSACTIVATION BY HUMAN T CELL LEUKEMIA VIRUS
- Diss Abstr Int [B]; 50(9):3846 1990. Unique Identifier : AIDSLINE ICDB/90665700
- Kitado H; Univ. of California, Irvine
- We have inserted sequences from the human T-cell leukemia viruses (HTLVs) that are responsive to tax, into the long terminal repeats (LTRs) of Moloney murine leukemia virus (M-MuLV). The inserted HTLV sequences conferred tax-response to the Moloney promoter in transient expression assays whether or not the Moloney enh
- [Seroprevalence of HTLV-I virus in the general population of six Central African countries]
- Int Conf AIDS. 1989 Jun 4-9;5:47 (abstract no. M.A.O.16). Unique Identifier : AIDSLINE ICA5/00001689
- Delaporte E; Peeters M; Durand JP; Porte P; Audoin J; Josse R; Centre International de Recherches Medicales, BP 769; Franceville, Gabon
- [Free and anonymous French Screening Centers - evaluation of 2 Parisron centers - City of Paris]
- Int Conf AIDS. 1989 Jun 4-9;5:49 (abstract no. M.A.O.24). Unique Identifier : AIDSLINE ICA5/00002489
- Cavelier A; Ancelle-Park R; Helal H; Loygue J; Poinsard R; Pretet S; D.A.S.E.S., Paris, France
- [Prevalence of HIV Infections and pulmonary Tuberculosis in an asymptomatic population in Haiti]
- Int Conf AIDS. 1989 Jun 4-9;5:50 (abstract no. M.A.O.29). Unique Identifier : AIDSLINE ICA5/00002989
- Lassegue A; Elie R; Hippolithe R; Cesar D; Cesar M; Centre Medical de Port-au-Prince, P-au-P, Haiti
- [Study of the risks of contamination by hepatitis B and HIV-1 virus in prison]
- Int Conf AIDS. 1989 Jun 4-9;5:52 (abstract no. M.A.O.40). Unique Identifier : AIDSLINE ICA5/00004189
- Espinoza P; Balian P; Bouchard I; Hopital de Fresnes Alle des Thuyas 94261 Fresnes Cedex France
- [Impact of the new definition of AIDS in Barcelona: the role of the tuberculosis patient]
- Int Conf AIDS. 1989 Jun 4-9;5:55 (abstract no. T.A.O.3). Unique Identifier : AIDSLINE ICA5/00005389
- Cayla JA; Plasencia A; Batalla J; Parellada N; Jansa JM; Institut Municipal de la Salut. Barcelona. Spain
- [HIV-1 and HIV-2 in a Dakar prison (Senegal)]
- Int Conf AIDS. 1989 Jun 4-9;5:81 (abstract no. M.A.P.19). Unique Identifier : AIDSLINE ICA5/00017589
- Samb ND; Boye CS; Diouf G; Siby T; Sow A; M'Boup S; Universite de Dakar, Senegal
- [Incidence of Hospitalization and HIV infections in prison]
- Int Conf AIDS. 1989 Jun 4-9;5:81 (abstract no. M.A.P.24). Unique Identifier : AIDSLINE ICA5/00018089
- Bouchard I; Espinoza P; Stein S; Polo Devoto J; D'Havillivillee P; Benamouzig R; Hopital de Fresnes (EHPNF) Allee des Thuyas 94261 Fresnes Cedex; France
- [Epidemiology of AIDS in prison]
- Int Conf AIDS. 1989 Jun 4-9;5:82 (abstract no. M.A.P.25). Unique Identifier : AIDSLINE ICA5/00018189
- Espinoza P; Bouchard I; Atkhen P; Polo DJ; Hopital de Fresnes (EHPNF) Allee des Thuyas 94261 Fresnes France
- [HIV seropositivity in blood donors and estimation of residual risk in transfusion]
- Int Conf AIDS. 1989 Jun 4-9;5:83 (abstract no. M.A.P.33). Unique Identifier : AIDSLINE ICA5/00018989
- Courouce AM; Groupe de travail Retrovirus de la Societe Nationale de; Transfusion Sanguine - Paris France
- HIV-1 infection in New York City STD clinic patients: evidence for stable seroprevalence, 1987-1988.
- Int Conf AIDS. 1989 Jun 4-9;5:89 (abstract no. M.A.P.67). Unique Identifier : AIDSLINE ICA5/00022489
- Weisfuse IB; Chiasson MA; Back S; Ramirez L; Greenberg B; Ewing W; New York City Department of Health, NY, NY. USA
- OBJECTIVE: To determine HIV-1 seroprevalence in patients at New York City STD clinics, and to compare rates over time in one clinic. METHODS: Blinded serosurveys were conducted among STD clinic patients in one clinic in 1987 and in all 12 STD clinics in 1988. The interval between the 2 surveys was 18 months. Specimens
- Characterization of HIV infected STD clinic clients identified through routine voluntary screening: implications for future health care needs.
- Int Conf AIDS. 1989 Jun 4-9;5:89 (abstract no. M.A.P.68). Unique Identifier : AIDSLINE ICA5/00022589
- Erickson B; Glasser D; Wasserheit JN; Rompalo AM; Brathwaite W; Hook EW; Baltimore City Health Dept., Baltimore, USA
- OBJECTIVE: To describe demographic and historical characteristics of HIV infected patients identified by a routine voluntary screening program in Baltimore STD clinics. METHODS: Consenting patients are screened for HIV-1 using commercially available EIA, confirmed using a licensed Western Blot test, and are given appo
- Frequency of HIV infection among patients of STD out-patient clinic.
- Int Conf AIDS. 1989 Jun 4-9;5:89 (abstract no. M.A.P.69). Unique Identifier : AIDSLINE ICA5/00022689
- Stapinski A; Mazurkiewicz W; Wojtowicz U; Napiorkowska T; Babiuch L; Medical Academy Warsaw, Poland
- OBJECTIVE: The incidence of HIV antibodies has been investigated in 1327 patients with various STD, 1022 males and 305 females, seen in the STD out-patient clinic. Sixty six males/6.5%/ were homosexuals or bisexuals. METHODS: The HIV antibodies were tested by the EIA method, and positive tests were confirmed by the We
- Analysis of trends over time in client characteristics at Minnesota (MN) HIV-1 antibody counseling and testing sites.
- Int Conf AIDS. 1989 Jun 4-9;5:89 (abstract no. M.A.P.70). Unique Identifier : AIDSLINE ICA5/00022789
- Danila R; Shultz J; Osterholm M; Henry K; Simpson M; MacDonald K; MN Dept. of Health, MN, USA
- OBJECTIVE: To evaluate the role of Minnesota HIV-1 antibody counseling and testing site programs (CTS) in HIV-1 transmission prevention efforts. METHODS: CTS client demographic and risk factor data were analyzed for 18,483 CTS clients with HIV-1 serology from 7/85-6/88. RESULTS: The highest seroprevalence rates were i
- Blind HIV-ab and syphilis-ab seroprevalence survey in New York State STD clinics.
- Int Conf AIDS. 1989 Jun 4-9;5:89 (abstract no. M.A.P.71). Unique Identifier : AIDSLINE ICA5/00022889
- DiFerdinando G; Arthur K; Hipp S; Murphy D; New York State (NYS) Department of Health, Albany, NY, USA
- OBJECTIVE: To monitor over time the HIV and syphilis seroprevalence among STD clients in all regions of NYS, excluding NYC. METHODS: Sera of clients receiving syphilis testing (RPR, FTA) at 19 STD clinics in 8 NYS counties during 1988 were tested anonymously for HIV (ELISA, WB). Clients were excluded if they had been
- HIV-1 infection in persons attending sexually transmitted disease (STD) clinics in Minnesota (MN).
- Int Conf AIDS. 1989 Jun 4-9;5:90 (abstract no. M.A.P.72). Unique Identifier : AIDSLINE ICA5/00022989
- Danila R; Henry K; Simpson M; Osterholm M; MacDonald K; MN Dept. of Health, MN, USA
- OBJECTIVE: To determine HIV-1 seroprevalence and risk factors associated with infection in persons attending STD clinics in Minnesota. METHODS: 1094 patients attending two STD clinics from 4/1/88-11/1/88 were systematically selected; participants were interviewed for HIV-1 infection risks and had blood drawn for HIV-1
- HIV seroprevalence of STD clinics in Houston, Texas, USA.
- Int Conf AIDS. 1989 Jun 4-9;5:90 (abstract no. M.A.P.73). Unique Identifier : AIDSLINE ICA5/00023089
- Enochs M; Falletti RL; Sullivan K; Sanchez D; Penaloza D; Honeycutt H; Bureau of Epidemiology, Houston Dept. of Health & Human Services,; Houston, Texas, USA
- OBJECTIVE: To present statistical data supporting the growing threat of HIV infection within specific sexually active populations attending an STD clinic. METHODS: A blinded survey was conducted at a large STD clinic servicing a predominantly black area of Houston. All blood samples taken for standard RPR screening we
- HIV seroprevalence in sexually transmitted disease clinics in Los Angeles County.
- Int Conf AIDS. 1989 Jun 4-9;5:90 (abstract no. M.A.P.74). Unique Identifier : AIDSLINE ICA5/00023189
- Ford WL; Rose T; Kerndt P; Onorato I; Waterman S; Los Angeles County Department of Health Services, Los Angeles,; California, USA
- OBJECTIVE: To estimate the seroprevalence of human immunodeficiency virus (HIV) among patients attending sexually transmitted disease (STD) clinics in Los Angeles County (LAC). METHODS: Between July and December 1988, consecutive attendees at 4 public STD clinics were screened for HIV Ab. Repeat ELISA positives were c
- Development and funding of public HIV counseling and testing services in the United States.
- Int Conf AIDS. 1989 Jun 4-9;5:90 (abstract no. M.A.P.75). Unique Identifier : AIDSLINE ICA5/00023289
- Cahill K; Bowen G; Kirby C; Centers for Disease Control (CDC), Atlanta, GA, USA
- OBJECTIVE: To describe the history and development of public sector funded HIV counseling and testing (CT) services in the U.S. since 1985. METHOD: We reviewed quarterly reports from State HIV/AIDS prevention programs and the CDC funding awards of State AIDS prevention cooperative agreements in order to document fundi
- Incidence of HIV infection in gay and bisexual men attending a counseling and testing site or an AIDS prevention program.
- Int Conf AIDS. 1989 Jun 4-9;5:90 (abstract no. M.A.P.76). Unique Identifier : AIDSLINE ICA5/00023389
- Cohn D; Koleis J; Cooper S; Cole V; Judson F; Denver Disease Control Service, Denver, CO, USA
- OBJECTIVE: To determine incidence of HIV infection in gay and bisexual men (GM) using a counseling and testing site (CTS) or enrolled in an AIDS Prevention longitudinal cohort study (APS). METHODS: GM who attended Denver s voluntary CTS from July, 1985 through December, 1988, and GM enrolled in APS from January, 1987
- HIV2 infection: some clinical and epidemiological aspects in Portugal.
- Int Conf AIDS. 1989 Jun 4-9;5:90 (abstract no. M.A.P.77). Unique Identifier : AIDSLINE ICA5/00023489
- Botas J; Tavares L; Carvalho C; Feliciano H; Antunes F; Dep. Inf. Diseases, Hosp. Sta Maria, Lisboa, Portugal
- OBJECTIVE: To assess the frequency of HIV2 infection in HIV seropositives studied at our Department. METHODS: The charts of 225 HIV seropositives (ELISA and Western blot) were analysed. Tests for HIV2 were performed in HIV1 negatives with disease, sexual partners of HIV2 positives or possibility of infection in Africa
- HIV-2 in Italy: no evidence, yet.
- Int Conf AIDS. 1989 Jun 4-9;5:91 (abstract no. M.A.P.78). Unique Identifier : AIDSLINE ICA5/00023589
- Cadeo GP; Corda L; Pizzocolo G; Albertini A; Carosi G; Dept. of Infectious Tropical Diseases, Dept. Chemistry,; University of Brescia, Brescia, Italy
- OBJECTIVE: The authors have carried out a wide-scale seroepidemiological survey in the region of Lombardy ( Italy ) to verify the presence of HIV-2 infection among risk categories. METHODS: 1069 subjects (946 drugs addicts, 80 homosexuals, 25 haemophiliacs and sexual partners) have be
- [Effectiveness of HIV-2 blood screening]
- Int Conf AIDS. 1989 Jun 4-9;5:92 (abstract no. M.A.P.85). Unique Identifier : AIDSLINE ICA5/00024289
- Courouce AM; groupe de travail Retrovirus de la Societe Nationale de; Transfusion Sanguine - Paris, France
- [Surveillance - health education of prostitutes in Senegal]
- Int Conf AIDS. 1989 Jun 4-9;5:97 (abstract no. M.A.P.117). Unique Identifier : AIDSLINE ICA5/00027389
- Siby T; Thior I; Sankale JL; Ndoye I; Gueye A; Mboup S; Bacterio-Virologie/Universite de Dakar
- [Control of quality in commercialized anti-HIV kits in France]
- Int Conf AIDS. 1989 Jun 4-9;5:97 (abstract no. M.A.P.118). Unique Identifier : AIDSLINE ICA5/00027489
- North M; Mouillot L; Courouce AM; Societe Nationale de Transfusion Sanguine, France
- [Evaluation of significance of a test using synthetic peptides (immunocomb) for the serologic diagnosis of HIV infections]
- Int Conf AIDS. 1989 Jun 4-9;5:97 (abstract no. M.A.P.119). Unique Identifier : AIDSLINE ICA5/00027589
- Rosenheim M; Ritterband M; Kerouedan D; Schwartz Y; M'Pele P; Gentilini M; Dpt de Medecine Tropicale et Unite INSERM 313, Hopital; Salpetriere, 47 Bd de 1'Hopital, 75013 Paris, France
- [HIV-1 virus in sickle cell anemia children after multiple transfusions in yaounde (Cameroun)]
- Int Conf AIDS. 1989 Jun 4-9;5:99 (abstract no. T.A.P.1). Unique Identifier : AIDSLINE ICA5/00027689
- Tetanye E; Nyouma E; Ndumbe P; Kaptue-Noche L; Centre Universitaire des Sciences de la Sante
- [Diffusion of sexual precautions and evolution of seropositivity in a french homosexual population: 1985 - 1988]
- Int Conf AIDS. 1989 Jun 4-9;5:102 (abstract no. T.A.P.19). Unique Identifier : AIDSLINE ICA5/00029489
- Pollak M; Schiltz MA; Boisson P; CNRS-GSPM, Paris
- [Hospital Surveillance of HIV infections in Bordeaux, France epidemiologic trends, 1985-1988]
- Int Conf AIDS. 1989 Jun 4-9;5:103 (abstract no. T.A.P.25). Unique Identifier : AIDSLINE ICA5/00030089
- Chaslerie A; Dupon M; Morlat P; Lacoste D; Pellegrin JL; Departement d'Informatique Medicale, Universite de Bordeaux; II, Bordeaux, France
- [Heterosexual transmission of HIV infections in sex partners of HIV seropositive drug abusers]
- Int Conf AIDS. 1989 Jun 4-9;5:117 (abstract no. T.A.P.111). Unique Identifier : AIDSLINE ICA5/00038689
- Errante I; Orso M; Meini M; Caggese L; Ferrazzi D; Schlacht I; Hopital Niguarda Ca' Granda-Milan
- [Analysis of trends in socio - demographic characteristics in AIDS cases reported in France]
- Int Conf AIDS. 1989 Jun 4-9;5:124 (abstract no. W.A.P.25). Unique Identifier : AIDSLINE ICA5/00042089
- Laporte A; Hubert B; Marciniak A; Cluzan S; Brunet JB; Direction Generale de la Sante, Paris, France
- [Outcome of HIV infected subjects: 1st results of a hospital surveillance]
- Int Conf AIDS. 1989 Jun 4-9;5:129 (abstract no. W.A.P.60). Unique Identifier : AIDSLINE ICA5/00045589
- Dabis F; Commenges D; Chene G; Pellegrin JL; Schmitt A; Departement d'Informatique Medicale, Universite de Bordeaux; II, France
- [HTLV-I in metropolitan France]
- Int Conf AIDS. 1989 Jun 4-9;5:147 (abstract no. Th.A.P.3). Unique Identifier : AIDSLINE ICA5/00051889
- Lemaire JM; Coste J; Courouce AM; CRTS - 34010 Montpellier, France
- [HIV-1 and HIV-2 coinfections in Martinique]
- Int Conf AIDS. 1989 Jun 4-9;5:145 (abstract no. Th.A.P.30). Unique Identifier : AIDSLINE ICA5/00054489
- Neisson-Vernant C; Monplaisir N; Chout R; Sobesky G; Demeleumesster R; Cales-Quist D; CHRU Fort-de-France
- [Adjustment of chronologic models with separation of the discriminant function]
- Int Conf AIDS. 1989 Jun 4-9;5:157 (abstract no. Th.A.P.99). Unique Identifier : AIDSLINE ICA5/00061389
- Prum B; Picard D; Rozenbaum W; Garbanzadeh D; Guihenneuc C; Universite Paris V
- [3 year surveillance of T4 lymphocytes and B2 microglobulin in a cohort of 166 subjects infected with HIV]
- Int Conf AIDS. 1989 Jun 4-9;5:166 (abstract no. A.531). Unique Identifier : AIDSLINE ICA5/00066589
- Brugnetti A; Negre M; Pesce A; Fuzibet JG; Quaranta JF; Dujardin P; Cassuto JP; C.H.R.U. de Nice, France
- [Modifications and geographical variations in transmission groups of HIV infections in France]
- Int Conf AIDS. 1989 Jun 4-9;5:167 (abstract no. A.539). Unique Identifier : AIDSLINE ICA5/00067389
- Jestin C; Ligue Francaise pour la Prevention des Maladies Infectieuses,; France
- [HIV, syphilis and drug abuse]
- Int Conf AIDS. 1989 Jun 4-9;5:168 (abstract no. A.543). Unique Identifier : AIDSLINE ICA5/00067789
- Espinoza P; Loubeyre JL; Benamouzig R; Bouchard I; Etablissement d'Hospitalisation Public National de Fresnes,; France
- [Epidemiological profile of infections due to human immunodeficiency virus (HIV) in Estrie]
- Int Conf AIDS. 1989 Jun 4-9;5:168 (abstract no. A.547). Unique Identifier : AIDSLINE ICA5/00068189
- Duperval R; Boivin D; Marcoux JA; Lepine M; Saad WP; Universite de Sherbrooke, Sherbrooke, Quebec, Canada
- [Coinfection with HIV-1 and HTLV-I]
- Int Conf AIDS. 1989 Jun 4-9;5:169 (abstract no. A.552). Unique Identifier : AIDSLINE ICA5/00068689
- Patey O; N'Go N; Dublanchet A; Lafaix C; Service des maladies infectieuses et tropicales, Villeneuve St; Georges-France
- [Evaluation of susceptibility to AIDS prevention in university students in Aix-Marseille]
- Int Conf AIDS. 1989 Jun 4-9;5:170 (abstract no. A.557). Unique Identifier : AIDSLINE ICA5/00069189
- Beresniak A; Enel P; Sambuc R; San Marco JL; Laboratoire de Sante Publique, Faculte de Medecine, Marseille,; France
- [Actual absence of HIV2 in Brazzaville (Congo)]
- Int Conf AIDS. 1989 Jun 4-9;5:172 (abstract no. A.558). Unique Identifier : AIDSLINE ICA5/00070289
- Yala F; Biendo M; Madzouka J; Copin N; Carme B; CHU BrazzavilleBP32, Brazzaville, Congo
- [IM-9 classification for HIV infections in the french experience of hospital morbidity]
- Int Conf AIDS. 1989 Jun 4-9;5:172 (abstract no. A.571). Unique Identifier : AIDSLINE ICA5/00070589
- Boulay F; Pibarot ML; Jestin C; Laporte A; Brunet JB; Direction des Hopitaux, Paris, France
- [High prevalence of HTLV-I and low prevalence of HIV in ivory coast lepers]
- Int Conf AIDS. 1989 Jun 4-9;5:175 (abstract no. A.587). Unique Identifier : AIDSLINE ICA5/00072189
- Sangare A; Verdier M; Sorro B; Gershy-Damet GM; Leonard G; Fran:cois D; Institut Pasteur et, Cote d'Ivoire
- [The demand for HIV serology examination in general medicine]
- Int Conf AIDS. 1989 Jun 4-9;5:176 (abstract no. A.595). Unique Identifier : AIDSLINE ICA5/00072889
- Van Casteren V; Stroobant A; Institut D'hygiene ET D'epidemiologie, Bruxelles, Belgique
- [Heterosexual transmission of HIV: hospital surveillance in Aquintaine, France - 1985-88]
- Int Conf AIDS. 1989 Jun 4-9;5:183 (abstract no. A.635). Unique Identifier : AIDSLINE ICA5/00076589
- Poumerol G; Chaslerie A; Morlat P; Lacoste D; Dupon M; Department d'Informatique Medicale, Universite de Bordeaux II,; Bordeaux, France
- [Epidemiological characteristics of new HIV seropositives in central-western France: evaluation of incidence and behavior]
- Int Conf AIDS. 1989 Jun 4-9;5:183 (abstract no. A.636). Unique Identifier : AIDSLINE ICA5/00076689
- Marchand S; Choutet P; CHRU Bretonneau, 37044 Tours France
- [Treatment of cerebral toxoplasmosis with clindamycin and 5-fluorouracil]
- Int Conf AIDS. 1989 Jun 4-9;5:193 (abstract no. M.B.O.36). Unique Identifier : AIDSLINE ICA5/00080589
- Eliaszewicz M; Kirstetter M; Meyohas MC; Frottier J; Hopital Saint-Antoine, Paris, France
- [Effects of prophylactic pentamidine aerosols on respiratory function in mid term]
- Int Conf AIDS. 1989 Jun 4-9;5:196 (abstract no. T.B.O.2). Unique Identifier : AIDSLINE ICA5/00082189
- Camus F; de Picciotto C; Lepretre A; Landman R; Girard PM; Saimot AG; Hopital Bichat-Claude Bernard, Paris, France
- [Study comparing the prevalence of HIV-1, HIV-2, and HTLV-I in lepers in 4 countries: Ivory Coast, Congo, Senegal, Yemen]
- Int Conf AIDS. 1989 Jun 4-9;5:197 (abstract no. T.B.O.9). Unique Identifier : AIDSLINE ICA5/00082889
- Mireille V; Sangare A; Sassou-Guesseau E; Gaye A; Al-Qubati Y; Denis F; Virologie et Neurologie CHU Dupuytren Limoges, France
- [Immunomodulators: alternative therapy associated with HIV infections]
- Int Conf AIDS. 1989 Jun 4-9;5:198 (abstract no. T.B.O.15). Unique Identifier : AIDSLINE ICA5/00083489
- Pompidou A; Faculte de Medecine Cochin Port Royal Paris
- [Circulating HIV-1 antigens]
- Int Conf AIDS. 1989 Jun 4-9;5:202 (abstract no. T.B.O.32). Unique Identifier : AIDSLINE ICA5/00085189
- Rouzioux C; Hopital Necker-Enfants Malades, Paris, France
- [Bacterial and viral pneumonias in AIDS patients who use I.V. drugs]
- Int Conf AIDS. 1989 Jun 4-9;5:214 (abstract no. Th.B.O.13). Unique Identifier : AIDSLINE ICA5/00092089
- Mouton Y; Chidiac C; Senneville E; Service Regional des Maladies Infectieuses, Centre Hospitalier; F-59208 Tourcoing, France
- Isoprinosine reduced clinical progression in HIV infected patients in a double blind placebo controlled study.
- Int Conf AIDS. 1989 Jun 4-9;5:219 (abstract no. Th.B.O.46). Unique Identifier : AIDSLINE ICA5/00095189
- Hidovre, Denmark
- OBJECTIVE: To determine the influence of isoprinosine (Imunovir) on the clinical course of HIV infection. METHODS: A total of 866 HIV infected patients from Sweden and Denmark were randomised and
- [Comparison of performances of ELISA reactants using a recombinant peptide for detection of HIV-2 infections]
- Int Conf AIDS. 1989 Jun 4-9;5:221 (abstract no. Th.B.O.55). Unique Identifier : AIDSLINE ICA5/00095989
- Catalan F; Milovanovic A; Ly TD; Odehouri K; Moreau J; Kadiot A; Institut Alfred Fournier - Paris - France
- [Epidemiological characteristics and clinical evolution of 45 pregnant patients seropositive for HIV]
- Int Conf AIDS. 1989 Jun 4-9;5:227 (abstract no. M.B.P.32). Unique Identifier : AIDSLINE ICA5/00099589
- Parnet-Mathieu F; Meyohas MC; Vincenti O; Barrat J; Eliaszewicz M; Brossard Y; Centre d'Hemobiologie Perinatale
- [Contribution of the CAT scan in diagnosing pulmonary complications of AIDS in the adult]
- Int Conf AIDS. 1989 Jun 4-9;5:228 (abstract no. M.B.P.41). Unique Identifier : AIDSLINE ICA5/00100489
- Trotot PM; Sandoz-Tronca C; Marichez M; Levillain R; Institut Pasteur
- [Diagnosis and treatment of cervico-vaginal and vulvar papilloma virus lesions in women seropositive for HIV virus]
- Int Conf AIDS. 1989 Jun 4-9;5:231 (abstract no. M.B.P.55). Unique Identifier : AIDSLINE ICA5/00101889
- Caubel P; Foulques H; Blondon J; Lefranc JP; Hopital de la Salpetriere, Paris, France
- [African disseminated histoplasmosis in a black child from Guinea-Bissau, seropositive for HIV-2]
- Int Conf AIDS. 1989 Jun 4-9;5:235 (abstract no. M.B.P.82). Unique Identifier : AIDSLINE ICA5/00104589
- Matos Almeida MJ; Service Dermatologie, Hosp. Sta Maria, Lisbonne Portugal
- [Pharmacokinetics (blood-spinal fluid) of large doses of acyclovir in HIV patients intravenous]
- Int Conf AIDS. 1989 Jun 4-9;5:236 (abstract no. M.B.P.88). Unique Identifier : AIDSLINE ICA5/00105189
- Chavanet P; Buisson M; Lokiec P; Aho S; Bielefeld P; Waldner A; Portier H; Hopital du Bocage, BP1542, 21034 Dijon cedex
- [Cryptococcosis, histoplasmosis and AIDS in the Congo]
- Int Conf AIDS. 1989 Jun 4-9;5:237 (abstract no. M.B.P.91). Unique Identifier : AIDSLINE ICA5/00105489
- Carme B; Mbitsi A; Ngolet A; Itoua-Ngaporo A; Ebikili B; Aya GM; Centre Hospitalier et Universitaire de Brazzaville, Congo
- [Transmission of HIV-1 by transfusion: a decreasing risk]
- Int Conf AIDS. 1989 Jun 4-9;5:247 (abstract no. M.B.P.151). Unique Identifier : AIDSLINE ICA5/00111489
- Jullien AM; Courouce AM; Richard D; Girard M; Elghouzzi MH; Habibi B; Fondation Nationale de Transf. Sang., Paris, France
- [Blood HIV antigens: systematic screening of blood donors in the parision region]
- Int Conf AIDS. 1989 Jun 4-9;5:247 (abstract no. M.B.P.154). Unique Identifier : AIDSLINE ICA5/00111789
- Vignon D; Transfustion Hopital Foch, Suresnes, France
- [Varicella and HIV infection]
- Int Conf AIDS. 1989 Jun 4-9;5:251 (abstract no. M.B.P.179). Unique Identifier : AIDSLINE ICA5/00114289
- Perronne C; Lazanas M; Leport C; Salmon D; Bricaire F; Vilde JL; Hopital Claude-Bernard, 75018 Paris, France
- [Cutaneous and veneral manifestations in patients infected with HIV in French Guiana]
- Int Conf AIDS. 1989 Jun 4-9;5:252 (abstract no. M.B.P.181). Unique Identifier : AIDSLINE ICA5/00114489
- Pradinaud R; Sainte-Marie D; Centre Hospitalier de Cayenne, Cayenne, Guyanne Fran:caise
- [Cutaneous and mucous membrane manifestations of African AIDS]
- Int Conf AIDS. 1989 Jun 4-9;5:252 (abstract no. M.B.P.183). Unique Identifier : AIDSLINE ICA5/00114689
- Coll AM; Ball MD; Benga E; Fatyndiaye C; Fayendao MA; Feller-Dansokho E; C.H.U. de Dakar, Service des Maladies infectieuses
- [Cutaneous manifestations of HIV infections in Rwanda]
- Int Conf AIDS. 1989 Jun 4-9;5:253 (abstract no. M.B.P.188). Unique Identifier : AIDSLINE ICA5/00115189
- Harelimana F; Bugingo G; Hopital Universitaire, Butare, Rwanda
- [Clinical aspects of HIV-1 and HIV-2 and classification by Bangui]
- Int Conf AIDS. 1989 Jun 4-9;5:254 (abstract no. M.B.P.195). Unique Identifier : AIDSLINE ICA5/00115889
- Sow AB; Coll AM; Fayendao MA; Diouf G; Feller-Dansokho E; Diop BM; Service des Maladies Infectieuses, C.H.U. de Dakar, Senegal
- [Surveillance by magnetic resonance imaging since October 1986 of a cohort of 50 HIV patients, initially asymptomatic]
- Int Conf AIDS. 1989 Jun 4-9;5:254 (abstract no. M.B.P.196). Unique Identifier : AIDSLINE ICA5/00115989
- Trotot PM; Cabanis EA; Lavayssiere R; Cabee AE; Thibierge M; Bigot JM; Vignaud J; Sandoz-Tronca C; Sansonetti PJ; Levillain R; et al; Institut Pasteur, Paris, France
- [Study of the protein S during an HIV infection]
- Int Conf AIDS. 1989 Jun 4-9;5:254 (abstract no. M.B.P.197). Unique Identifier : AIDSLINE ICA5/00116089
- Lebret-Lerolle D; Pulik M; Jari L; Teillet-Thiebaud F; Cannesson G; Teillet F; Hopital Louis Mourier, Colombes, France
- [Ocular toxoplasmosis during AIDS]
- Int Conf AIDS. 1989 Jun 4-9;5:259 (abstract no. M.B.P.225). Unique Identifier : AIDSLINE ICA5/00118889
- Fegueux S; Sazoun L; Matheron S; de Truchis P; Couland JP; Saimot AG; Hopital Bichat-Claude Bernard, Paris, France
- [Ocular toxoplasmosis during AIDS]
- Int Conf AIDS. 1989 Jun 4-9;5:259 (abstract no. M.B.P.226). Unique Identifier : AIDSLINE ICA5/00118989
- Chakroun M; Meyohas MC; Pelosse B; Zazoun L; Vacherot B; Leport C; Hopital Claude Bernard, Paris, France
- [Thrombotic microangiopathy and HIV infection]
- Int Conf AIDS. 1989 Jun 4-9;5:263 (abstract no. M.B.P.249). Unique Identifier : AIDSLINE ICA5/00121289
- Khuong M; De Truchis P; Oksenhendler E; Matheron S; Dosquet P; Clauvel JP; Hopital Bichat-Claude Bernard, Paris, France
- [Prospective study on coagulation anomalies in 156 consecutive patients seropositive for HIV]
- Int Conf AIDS. 1989 Jun 4-9;5:263 (abstract no. M.B.P.250). Unique Identifier : AIDSLINE ICA5/00121389
- Taillan B; Roul C; Fuzibet JG; Vinti H; Pesce A; Bayle J; Cassuto JP; Dujardin P; C.H.R.U. de Nice, France
- [Are chronic lymphadenopathies evidence of an aggravation of the immunodeficiency tied to HIV? Cohort study of 264 seropositive subjects, Bordeaux, France]
- Int Conf AIDS. 1989 Jun 4-9;5:264 (abstract no. M.B.P.254). Unique Identifier : AIDSLINE ICA5/00121789
- Morlat P; Lacoste D; Msellati P; Dupon M; Pellegrin JL; Centre Hospitalier Regional Universitaire (CHRU), Bordeaux,; France
- [Nursing care and the AIDS epidemic]
- Int Conf AIDS. 1989 Jun 4-9;5:274 (abstract no. M.B.P.316). Unique Identifier : AIDSLINE ICA5/00127989
- Schneeberger C; Assistance Publique, Villejuif, France
- [Evaluation of active T lymphocytes and natural killer subpopulations during treatment of ARC patients with zidouudine]
- Int Conf AIDS. 1989 Jun 4-9;5:279 (abstract no. M.B.P.347). Unique Identifier : AIDSLINE ICA5/00131089
- Levacher M; Dournon E; Tallet S; Rouveix B; Pocidalo JJ; INSERM U.13, 10, Avenue de la Porte d'Aubervilliers 75944 Paris,; France
- [In the patient, only a fraction of the retrovirus infection seems sensitive to AZT]
- Int Conf AIDS. 1989 Jun 4-9;5:280 (abstract no. M.B.P.350). Unique Identifier : AIDSLINE ICA5/00131389
- Mathez D; Leibowitch J; Cesari D; Belilovsky C; Gorin I; Deleuze J; Paul D; Hopital Raymond-Poincare/Universite Rene-Descartes,; Garches/Paris-ouest, France
- [Prevalence of psychiatric disorders in patients hospitalized for AIDS]
- Int Conf AIDS. 1989 Jun 4-9;5:286 (abstract no. M.B.P.384). Unique Identifier : AIDSLINE ICA5/00134789
- Zamperetti M; Ferrazzi D; Schlacht I; Cusini M; Muratori S; Zerboni R; Servizio Psichiatrico Origgi I (Responsible Prof.G.F.Goldwurn); Ospedale Ca Granda Niguarda - Milano - Italy
- [Quantitative evaluation of parasitism in pneumocytosis in patients with AIDS or other immunodepressions]
- Int Conf AIDS. 1989 Jun 4-9;5:287 (abstract no. T.B.P.1). Unique Identifier : AIDSLINE ICA5/00134889
- Roux P; Parrot A; Denis M; Mayaud C; Parquin F; Lancastre F; Hopital Tenon - 4, rue de la chine - 75020 - Paris
- [Significance and limitations of induced expectorations in the diagnosis of AIDS pneumocytosis]
- Int Conf AIDS. 1989 Jun 4-9;5:287 (abstract no. T.B.P.4). Unique Identifier : AIDSLINE ICA5/00135189
- Delacour T; Roux P; Camus F; Fay M; Denis M; Girard PM; Hopital Tenon, Paris, France
- [Pneumocystosis and AIDS in Brazzaville, Congo]
- Int Conf AIDS. 1989 Jun 4-9;5:290 (abstract no. T.B.P.19). Unique Identifier : AIDSLINE ICA5/00136689
- Carme B; Mboussa J; Mpele P; Datry A; Mouanga-Yidika G; Itoua-Ngaporo A; Centre Hospitalier et Universitaire de Brazzaville, Congo
- [Treatment of AIDS pneumocystosis with DFMO]
- Int Conf AIDS. 1989 Jun 4-9;5:291 (abstract no. T.B.P.27). Unique Identifier : AIDSLINE ICA5/00137489
- Girard PM; Garou A; Rozenbaum W; Perronne C; Wolff M; Coulaud JP; Hopital Bichat - Claude Bernard, Paris, France
- [Treatment of pneumocystosis with cotrimoxazole]
- Int Conf AIDS. 1989 Jun 4-9;5:293 (abstract no. T.B.P.41). Unique Identifier : AIDSLINE ICA5/00138889
- Traore B; Eckert D; Rosenheim M; Gentilini M; Department de Medecine Tropicale, Sante Publique et; Parasitologie Universite de Paris VII. France
- [Use of fansidar for pneumocystosis and toxoplasmosis prophylaxis]
- Int Conf AIDS. 1989 Jun 4-9;5:294 (abstract no. T.B.P.47). Unique Identifier : AIDSLINE ICA5/00139489
- Livrozet JM; Mounilaila K; Garin JP; Mojon M; Garnier JL; Touraine JL; Hopital E. Herriot, PAV.P, Place D'arsonval, 69437 Lyon CX3; France
- [Prevention of pneumocystosis recurrence by pentamidine aerosols: prospective randomized study of AIDS patients treated by AZT]
- Int Conf AIDS. 1989 Jun 4-9;5:295 (abstract no. T.B.P.49). Unique Identifier : AIDSLINE ICA5/00139689
- Girard PM; Landman R; Gaudebout C; Lepretre A; Michon C; Saimot AG; Hopital Bichat - Claude Bernard, Paris, France
- [Secondary prophylaxis of pulmonary pneumocytosis with aerosol pentamidine]
- Int Conf AIDS. 1989 Jun 4-9;5:298 (abstract no. T.B.P.71). Unique Identifier : AIDSLINE ICA5/00141889
- Eliaszewicz M; Lacassin F; Lebas J; Meyohas MC; Perrin M; Picard O; Hopital Saint-Antoine, Paris, France
- [Effectiveness and safety in aerosol pentamidine prophylaxis in Italian I.V. drug abusers affected by AIDS, in zidovudine therapy]
- Int Conf AIDS. 1989 Jun 4-9;5:298 (abstract no. T.B.P.74). Unique Identifier : AIDSLINE ICA5/00142189
- Gafa S; Giudici MG; Vezzani F; Tuzza A; Calonghi GF; Malattie Infettive, Arcispedale S.Maria Nuova, Reggio Emilia,; Italy
- [Blood HIV antigens during the first infection]
- Int Conf AIDS. 1989 Jun 4-9;5:301 (abstract no. T.B.P.90). Unique Identifier : AIDSLINE ICA5/00143789
- Schiavini D; Puel J; Averous S; Bazex J; Laboratoire de Virologie, CHU Purpan, Toulouse, France
- [Aptitude of a rapid test for anti HIV and agglutination tests for detecting anti-HIV-2 antibodies in Senegal]
- Int Conf AIDS. 1989 Jun 4-9;5:304 (abstract no. T.B.P.105). Unique Identifier : AIDSLINE ICA5/00145289
- Mboup S; Sankale JL; Kabeya CM; Diakhate L; Thiam D; Mitchell S; Bacterio-Virologie/Universite de Dakar
- [Frequency of HIV virus isolation in the blood and vaginal secretions of seropositive women]
- Int Conf AIDS. 1989 Jun 4-9;5:305 (abstract no. T.B.P.113). Unique Identifier : AIDSLINE ICA5/00146089
- Ly TD; Hoffmeister-Barcellos S; Henrion G; Coulaud JP; Catalan F; Institut Alfred Fournier - Paris
- [Reflections on isolation of HIV in a virology hospital unit]
- Int Conf AIDS. 1989 Jun 4-9;5:306 (abstract no. T.B.P.115). Unique Identifier : AIDSLINE ICA5/00146289
- Fleury HJ; Delord B; Masquelier B; Laboratoire de Virologie, CHR de Bordeaux et Universite de; Bordeaux II, Bordeaux, France
- [Evaluation of a test of rapid detection for HIV-1 and HIV-2 seropositive subjects]
- Int Conf AIDS. 1989 Jun 4-9;5:306 (abstract no. T.B.P.120). Unique Identifier : AIDSLINE ICA5/00146789
- Catalan F; Milovanovic A; Ly TD; Institut Alfred Fournier - Paris
- Longitudinal evaluation of immunologic and viral markers of HIV infection in children: clinical correlation.
- Int Conf AIDS. 1989 Jun 4-9;5:315 (abstract no. T.B.P.172). Unique Identifier : AIDSLINE ICA5/00151889
- Hernandez-Sampelayo T; Perez Alvarez L; Gurbindo MD; Munoz L; Fermosel J; Casado C; Instituto de Salud Carlos III: Unidad de SIDA, Madrid, Spain
- OBJECTIVE: To determine the proportion of HIV infected newborn to HIV Ab+newborn and define changes of immunologic and viral markers that correlate with disease stage, to determine predictive prognostic markers of HIV infection in children. METHODS: We studied 35 HIV+ children born to HIV+ drug abuser mothers, ELISA(E
- [Severe and early neurologic expression in a newborn infected with HIV virus]
- Int Conf AIDS. 1989 Jun 4-9;5:318 (abstract no. T.B.P.187). Unique Identifier : AIDSLINE ICA5/00153389
- Tricoire J; Rolland M; Robert A; Delisle MB; Puel J; Berrebi A; P-ediatrie B, CHU Purpan, 31059 Toulouse C-edex, France
- [Predictive value of clinical and biological status of HIV mothers on their infants' status]
- Int Conf AIDS. 1989 Jun 4-9;5:319 (abstract no. T.B.P.195). Unique Identifier : AIDSLINE ICA5/00154189
- Matheron S; Di Maria H; Courpotin C; Brun-Vezinet F; Dormont D; Balloul H; Hopital Bichat, Paris, France
- Cryptosporidium SP and Isospora belli infections in pediatric patients.
- Unique Identifier : AIDSLINE ICA5/00154289
- De Paula MD; Queiroz W; Janini M; Soraggi C; Hughes V; Rodriguez C; Hospital Emilio Ribas, Sao Paulo, Brazil
- OBJECTIVE: It is known that Isospora belli and Cryptosporidium sp are protozoa very frequently associated with acute self limited diarrheal illness in children and young adults. This evolution is not observed among immunocompromised individuals. This report shows the prevalence of Cryptosporidiosis and Isosporiasis in
- Natural history of AIDS in children of African origin seen in Belgium: evidence for two patterns.
- Int Conf AIDS. 1989 Jun 4-9;5:319 (abstract no. T.B.P.197). Unique Identifier : AIDSLINE ICA5/00154389
- Jonckheer T; Levy J; Alimenti A; Francois A; Ninane J; Institute of Tropical Medicine, Antwerp, Belgium
- OBJECTIVE: To describe the diseases indicative of AIDS in children of African origin seen in Belgium . METHODS: The children of African origin with at least one disease indicative of AIDS according to the latest CDC-case definition were selected. RESULTS: Forty-four children met th
- Perinatal transmission of HIV-1: is a decreased CD4 cell count predictive?
- Int Conf AIDS. 1989 Jun 4-9;5:320 (abstract no. T.B.P.198). Unique Identifier : AIDSLINE ICA5/00154489
- Dattel BJ; Hauer LB; Wofsy CB; Crombleholme W; Weintrub P; Wara D; Sweet RL; University of California, San Francisco, San Francisco General; Hospital, USA
- OBJECTIVE: To investigate possible immunologic, virologic and/or clinical factors which might correlate with perinatal transmission of HIV-1. METHODS: Pregnant HIV+ women were followed prenatally and postpartum with testing for immune function, HIV-1 in peripheral blood, and P24 Antigen (Ag). Infants were considered i
- Pulmonary infectious complications in pediatric AIDS patients.
- Int Conf AIDS. 1989 Jun 4-9;5:320 (abstract no. T.B.P.199). Unique Identifier : AIDSLINE ICA5/00154589
- De Paula MD; Janini M; Queiroz W; Hughes V; Rodriguez C; Loren:co R; Hospital Emilio Ribas, Sao Paulo, Brazil
- OBJECTIVE: Infectious pulmonary processes are very common among HIV infected children. This report shows the etiologic agents more frequently associated with pulmonary disease among our children. METHODS: From January/86 up to November/88, 42 children aged from 2 months to 10 years were followed monthly. All of them f
- Perinatal and heterosexual transmission through HIV-positive women.
- Int Conf AIDS. 1989 Jun 4-9;5:320 (abstract no. T.B.P.200). Unique Identifier : AIDSLINE ICA5/00154689
- Rehmet S; Staszewski S; Wegerich B; Kreuz W; Stille W; Zentrum der Inneren Medizin, Universitatsklinik Frankfurt, FRG
- Since 1984, we have examined HIV-infected women and their partners in order to gain information on infectivity, perinatal and heterosexual transmission rates, and possible relations between these factors. 44 women examined in this period had borne a total of 47 children since their HIV infection. 10 children are posit
- Immunological, serological and clinical evaluation of HIV pos. pregnant women in relation to vertical transmission of HIV.
- Int Conf AIDS. 1989 Jun 4-9;5:320 (abstract no. T.B.P.201). Unique Identifier : AIDSLINE ICA5/00154789
- Muggiasca ML; Conti M; Zanchetta N; Salvaggio L; Novati R; Massironi E; VII dep. Obste. Gynecol., University of Milan. Milan, Italy
- OBJECTIVE: To evaluate the prevalence of vertical transmission of HIV in relation to immunity, HIV related diseases and viral replication in their mothers. METHODS: 23 HIV pos. pregnant women (6 IVDA; 13 ex-IVDA; 3 partners of HIV) have been clinically evaluated and tested for HIV circulating antigen (p24 Ag, Elisa, A
- Clinical and serologic prospective study in infants born from HIV seropositive mothers.
- Int Conf AIDS. 1989 Jun 4-9;5:320 (abstract no. T.B.P.202). Unique Identifier : AIDSLINE ICA5/00154889
- Fortuny C; Sanchez C; Barrera JM; Ercilla MG; Navio D; Jimenez R; Gelabert A; Dept. Pediatry and Blood Transmitted Diseases Unit. Hospital; Clinic. Villarroel 170. Barcelona. Spain
- OBJECTIVE: To evaluate the serological and clinical evolution of newborns (NB) from seropositive mothers. METHODS: 70 NB were clinically controlled monthly and serologically (HIV-Ab, HIV-Ag) each two months. RESULTS: At birth all NB showed IgG Ab against HIV-1 with a mirror pattern in Western blot (WB) when compared w
- Ophthalmic manifestations of HIV infection in an African pediatric population.
- Int Conf AIDS. 1989 Jun 4-9;5:321 (abstract no. T.B.P.203). Unique Identifier : AIDSLINE ICA5/00154989
- Kestelyn P; Lepage P; Stevens AM; Van de Perre P; Department of Ophthalmology and Department of Pediatrics, Centre; Hospitalier de Kigali, National AIDS program, Kigali, Rwanda,; Africa
- OBJECTIVE: HIV infection in adults is associated with a wide variety of ophthalmic manifestations. The purpose of this study was to investigate the spectrum of ophthalmic involvement in a pediatric HIV seropositive population. METHODS: All seropositive children attending the department of pediatrics of the Centre Hosp
- Anthropocentric measures in a cohort of children born to HIV women in Kinshasa, Zaire.
- Int Conf AIDS. 1989 Jun 4-9;5:321 (abstract no. T.B.P.204). Unique Identifier : AIDSLINE ICA5/00155089
- Hassig SE; Manzila T; Nsa W; Kashamuka M; Ryder R; Projet SIDA, Kinshasa, Zaire; Tulane University, New Orleans, USA
- OBJECTIVES: To determine the prevalence and correlates of wasting and stunting in a cohort of children born to HIV+ women. METHODS: Monthly weights, heights and illness experience (diarrhea, pneumonia, fever) were collected on 366 children born to HIV+ women and 513 children born to HIV- women. Weight-for-height (wast
- High HIV-associated infant mortality correlates with poor post-partum maternal health: 18 months follow-up of 477 children (CH) born to HIV(+) mothers (MO) in Zaire.
- Int Conf AIDS. 1989 Jun 4-9;5:321 (abstract no. T.B.P.205). Unique Identifier : AIDSLINE ICA5/00155189
- Badi N; Ryder R; Nsuami M; Matela B; Nsa W; Projet SIDA, Kinshasa, Zaire
- OBJECTIVES: To determine mortality/1000 live births and associated postpartum maternal risk factors in CH with perinatally-acquired HIV infection (PI). METHODS: Infant cause of death and maternal factors predictive of PI and infant mortality were prospectively determined during the 18 month postpartum period in 3 grou
- Perinatal immune function in offspring of HIV seronegative women at risk for AIDS.
- Int Conf AIDS. 1989 Jun 4-9;5:321 (abstract no. T.B.P.206). Unique Identifier : AIDSLINE ICA5/00155289
- Rich K; Landay A; Chasnoff I; University of Illinois, Chicago, IL, USA
- OBJECTIVE: To examine possible association of maternal immune function on the immunologic function of infants less than or equal to 6 weeks old. METHODS: Substance abusing women at risk for HIV infection and their infants less than or equal to 6 wks. old were tested for their immune function. Patients were excluded if
- ADCC in HIV-1 infected children.
- Int Conf AIDS. 1989 Jun 4-9;5:321 (abstract no. T.B.P.207). Unique Identifier : AIDSLINE ICA5/00155389
- Walter E; McKinney R; Wilfert C; Tyler D; Bolognesi D; Weinhold K; Duke University Medical Center, Durham, NC, USA
- OBJECTIVE: To determine the prevalence of antibodies directing gp120 specific antibody-dependent cellular cytotoxicity (ADCC) within a cohort of HIV-1 infected children. METHODS: Sera from 35 HIV-1 infected and 10 seronegative children (ages 1 mos-13 yrs) were evaluated for ADCC directing activities in a series of 6-h
- Longterm follow-up of immunologic parameters in HIV-exposed infants.
- Int Conf AIDS. 1989 Jun 4-9;5:321 (abstract no. T.B.P.208). Unique Identifier : AIDSLINE ICA5/00155489
- Wintergerst; Rosendahl WR; Lutz R; Fahrenheim E; Belohradsky BH; immundefekt-Ambulanz der Universitats-Kinderkliniken,; Lindwurmstr.4, 8000 Munchen 2, West-Germany
- INTRODUCTION: Infants with ARC or AIDS following vertically acquired HIV-infection develop severe B- and T-cell defects. The longterm follow-up of immunologic parameters was studied in vertically HIV-infected versus HIV-exposed infants, who became HIV-Ab negative and were otherwise healthy. METHODS: Since 1985 35 chil
- HIV-specific immune responses in congenital HIV infection.
- Int Conf AIDS. 1989 Jun 4-9;5:321 (abstract no. T.B.P.209). Unique Identifier : AIDSLINE ICA5/00155589
- Luzuriaga K; Koup R; Panicali D; Sullivan J; University of Massachusetts Medical School, Worcester,; Massachusetts, USA
- OBJECTIVE: To investigate HIV-specific immune responses in infants and children with congenital HIV infection. METHODS: Diagnosis of HIV infection was made in 7 children by viral isolation. HIV-specific antibody-dependent cell-mediated cytotoxicity (ADCC) was studied in all of the children using an EBV-transformed lym
- HIV infection in infants: natural history and outcome.
- Int Conf AIDS. 1989 Jun 4-9;5:322 (abstract no. T.B.P.210). Unique Identifier : AIDSLINE ICA5/00155689
- Johnson JP; Nair P; Advani M; O'Neil K; Seiden S; Hines S; University of Maryland School of Medicine, Baltimore, Maryland,; USA
- OBJECTIVE: To determine the natural history and outcome of HIV infection in infants. METHODS: 35 children born to seropositive women were followed from birth to 18 months. Physical exam and laboratory data were collected at 2,4,6,9 and 12 months of age. Nine of these children were confirmed infected by increasing IgG
- Perinatal transmission of HIV - indicators of infection.
- Int Conf AIDS. 1989 Jun 4-9;5:322 (abstract no. T.B.P.211). Unique Identifier : AIDSLINE ICA5/00155789
- Mok J; Hague RA; Hargreaves FD; Whitelaw J; Yap PL; City Hospital, Edinburgh, HIV Immunology Lab, Western General; Hospital, Edinburgh, United Kingdom
- OBJECTIVE: To define the natural history of vertically acquired HIV infection and to elicit methods for early diagnosis. METHODS: Forty nine index infants born to HIV seropositive mothers have been followed up for a median duration of 27 months, together with 24 control infants of HIV seronegative mothers. RESULTS: Cl
- Serum interleukin 2 receptor (sIL-2R) levels in neonates born of HIV-infected mothers: preliminary results.
- Int Conf AIDS. 1989 Jun 4-9;5:322 (abstract no. T.B.P.212). Unique Identifier : AIDSLINE ICA5/00155889
- Ridolfo AL; Galli M; d'Arminio MA; Cocchi F; Novati R; Marchisio P; Massironi P; Balotta C; Infectious Diseases Clinic; University of Milan, Italy
- OBJECTIVE: To state whether sIL-2R levels present any difference between infected and non-infected neonates. METHODS: sIL-2R serum samples were quantified using an ELISA method (T Cell Science) in the 7th and 14th month in 13 neonates born of anti-HIV positive mothers. IgG anti-HIV (ELISA, Abbott; Western Blot, WB-DuP
- Serum neutrophil antibodies in children with HIV infection.
- Int Conf AIDS. 1989 Jun 4-9;5:322 (abstract no. T.B.P.213). Unique Identifier : AIDSLINE ICA5/00155989
- Church JA; Beyer L; Coates T; Childrens Hospital of Los Angeles, and U.S.C. School of Medicine,; Los Angeles, California, USA
- OBJECTIVE: To determine the prevalence of serum neutrophil antibodies (NA) in children with HIV infection and the relationship of NA to neutropenia in these patients. METHODS: Serum was obtained from 18 HIV-infected children, 9M, 9F, 1 to 7 years of age (mean 3.5 +/- 1.5). 3 were asymptomatic (P-1), 6 had ARC (P-2A,F)
- Immunological abnormalities in HIV infection by vertical transmission.
- Int Conf AIDS. 1989 Jun 4-9;5:322 (abstract no. T.B.P.214). Unique Identifier : AIDSLINE ICA5/00156089
- Espanol T; Curell N; Figuera T; Quer J; Garcia X; Caragol I; Immunology and Pediatric Infectious Diseases Units. R.S. Valle; Hebron. Barcelona. Spain
- The first risk for AIDS in Spain is drug addiction and the number of cases by vertical transmission is 2,6% of the total. Immunological abnormalities are very severe in children infected during pregnancy or perinatally, and early diagnosis is important to establish therapeutic proto
- Immunoglobulin E (IgE) in children with acquired immunodeficiency syndrome (AIDS).
- Int Conf AIDS. 1989 Jun 4-9;5:322 (abstract no. T.B.P.215). Unique Identifier : AIDSLINE ICA5/00156189
- Gurbindo Gutierrez MD; Tornero P; del Moral A; Fermosel J; Hernandez-Sampelayo T; Hospital General Grerorio Maranon. Madrid. Spain
- Serum IgE levels are increased in some congenital T-Cell deficiencies and autoimmune disorders. IgE synthesis is regulated by cooperation between T helper and B cells. Patients infected by Human Immunodeficiency Virus (HIV) show an early increase in serum IgG and IgA, indicating and B-cell polyclonal activation. To de
- Early detection of HIV in childhood.
- Int Conf AIDS. 1989 Jun 4-9;5:323 (abstract no. T.B.P.216). Unique Identifier : AIDSLINE ICA5/00156289
- Castillo I; Ruiz-Moreno M; Onenaca F; Varas F; Zanora L; Carreno V; Hepatology Unit, S. Hospital, Madrid, Spain
- It is unclear the fiability of the anti-HIV detection in children from HIV seropositive mothers, as the maternal antibodies and the p24 antigen (HIVAg) remain in children for a mean time of 9-10 months. For this it is necessary to develop new diagnostic techniques for the early identification of the current HIV infect
- Detection of specific IgM antibody by radioimmunoprecipitation assay for early diagnosis of HIV infection in infants.
- Int Conf AIDS. 1989 Jun 4-9;5:323 (abstract no. T.B.P.217). Unique Identifier : AIDSLINE ICA5/00156389
- Fauvel M; Lecomte J; Claessens C; Samson J; Lapointe N; Laboratoire de sante publique du Quebec, Montreal, Canada
- OBJECTIVE: To evaluate IgM-specific HIV antibody (Ab) by radioimmunoprecipitation assay (RIPA) in infants born to seropositive mothers as a tool for early diagnosis. METHODS: Sequential sera from 5 HIV-infected infants were analyzed by standard RIPA with protein-A Sepharose and by RIPA-IgM. For the latter, CNBr-activa
- IgG subclass concentrations and antibody levels to bacterial toxoids in children with human deficiency virus (HIV).
- Int Conf AIDS. 1989 Jun 4-9;5:323 (abstract no. T.B.P.218). Unique Identifier : AIDSLINE ICA5/00156489
- Kreuz W; Enenkel S; Zlelen S; Gungor T; Haas S; Wegerich B; Bauscher P; Ahrens P; Rehmet S; Hofmann D; et al; Klinikum der JW Goethe-Universitat Frankfurt (Main) FRG
- Infection with HIV leads to a combined Immunodefect. As a result of polyclonal B-cell activation there is a significant increase in the serum immunoglobulin levels. The specific humoral immune response is, however, usually impaired. We have investigated to what extent the levels of IgG subclasses undergo change as a r
- [Quantitative Western blot: surveillance of HIV seropositive newborns]
- Int Conf AIDS. 1989 Jun 4-9;5:323 (abstract no. T.B.P.219). Unique Identifier : AIDSLINE ICA5/00156589
- Schiavini D; Puel J; Rousseau A; Gayet-Mengelle C; Laboratoire de Virologie, CHU Purpan, Toulouse, France
- Serologic response to HIV infection in infants.
- Int Conf AIDS. 1989 Jun 4-9;5:323 (abstract no. T.B.P.220). Unique Identifier : AIDSLINE ICA5/00156689
- Johnson JP; Davis E; Shinaberry R; Nair P; University of Maryland School of Medicine, Baltimore, Md, USA
- OBJECTIVE: To document the antibody response to HIV infection in neonates. METHODS: Blood was collected from 35 children born to seropositive women at 2,4,6, and 12 months. Serum was assayed using the DuPont HIV ELISA and P24 assay. IgG and IgM Western blots were run using strips from Organon-Technica and sequential a
- The use of anti-HIV IgM immunoblot in the diagnosis of neonatal HIV infection: a report of 5 cases.
- Int Conf AIDS. 1989 Jun 4-9;5:323 (abstract no. T.B.P.221). Unique Identifier : AIDSLINE ICA5/00156789
- Panmoung W; Sirivichayakul S; Chumdermpadetsuk S; Likitnukul S; Phanuphak P; Chulalongkorn University Hospital, Bangkok, Thailand
- OBJECTIVE: To evaluate the reliability of anti-HIV IgM immunoblot in the early diagnosis of HIV infection in babies of HIV-infected mothers. METHODS: Paired maternal and cord blood from 5 babies at Chulalongkorn University Hospital from HIV-infected intravenous heroin abusing mothers were studied. Anti-HIV IgM immunob
- Is the IgM antibodies status a useful marker to assess the neonates contamination by HIV-1?
- Int Conf AIDS. 1989 Jun 4-9;5:324 (abstract no. T.B.P.222). Unique Identifier : AIDSLINE ICA5/00156889
- Gayet-Mengelle C; Puel J; Tricoire J; Rousseau A; Laboratoire de Virologie, CHU Purpan, Toulouse, France
- OBJECTIVE: Realization of an early diagnosis of congenital or neonatal transmission in order to initiate an immediate therapy against HIV-1. METHODS: We tested IgM antibodies in 53 neonates born to intravenous drug abusers (N=45) heterosexually contaminated (N=7) and unknown mothers (N=1) using the Western-blot assay
- Enumeration of peripheral blood antibody-secreting cells as a diagnostic aid for HIV infection in children.
- Int Conf AIDS. 1989 Jun 4-9;5:324 (abstract no. T.B.P.223). Unique Identifier : AIDSLINE ICA5/00156989
- Nahmias A; Lee F; Nesheim S; O'Neil C; Muther J; Slade B; Depts. of Pediatrics and Pathology, Emory University, Atlanta,; GA, USA
- OBJECTIVE: To evaluate the enzyme-linked immunoblot (ELISPOT) for diagnosis of HIV infection in symptomatic children and infants born to seropos. mothers. METHODS: The ELISPOT, using a gP41 recombinant protein, was applied to peripheral blood mononuclear cells (PBMC) obtained from 31 negative children, 28 children wit
- Recovery of HIV from lymphocytes and monocytes of symptomatic HIV infected children.
- Int Conf AIDS. 1989 Jun 4-9;5:324 (abstract no. T.B.P.224). Unique Identifier : AIDSLINE ICA5/00157089
- Landay AL; Chadwick EG; Kucik S; Yogev R; Rush Medical Center, Chicago, IL, USA
- OBJECTIVE: Correlation of immunologic and virologic findings with clinical status in perinatally HIV-infected children. METHODS: HIV antibody (Ab+) and antigen (Ag+) status was determined by commercial EIA procedures. CD4 and CD8 lymphocyte analysis was performed by a whole blood lysis procedure and analyzed by dual p
- Neopterin - potential early marker of perinatal HIV infection.
- Int Conf AIDS. 1989 Jun 4-9;5:324 (abstract no. T.B.P.225). Unique Identifier : AIDSLINE ICA5/00157189
- Lischner HW; Bagasra O; Raphael SA; Treston CS; Shandilya L; Temple Univ & St Christopher's Hosp for Children, Philadelphia,; PA, USA
- OBJECTIVE: To test the hypothesis that neopterin (N) levels can differentiate infected from non-infected infants and children of HIV-infected mothers. METHODS: N was determined by 125I radioimmunoassay (DRG, Berlin) in 58 serum and/or EDTA plasma specimens from 40 children of HIV-infected mothers 1 to 59 mo of AGE AND
- High prevalence of HIV-specific IgA and IgG-specific IgM antibodies in neonates of HIV-positive mothers.
- Int Conf AIDS. 1989 Jun 4-9;5:324 (abstract no. T.B.P.226). Unique Identifier : AIDSLINE ICA5/00157289
- Schupbach J; Wunderli W; Kind C; Kernen R; Baumgartner A; Tomasik Z; Swiss National Center for Retroviruses, Institute of Immunology; and Virology, University of Zurich, Zurich, Switzerland
- OBJECTIVE: To analyze the specificity of Western blot (WB)-reactive IgM and IgA in cord bloods. METHODS: Cord blood of 21 babies of HIV+ mothers was tested for HIV-specific IgM or IgA by WB. Preabsorptions of IgG with immobilized protein A or G were done to determine whether reactions were mediated by HIV-specific IgM
- Prospective study of polymerase chain reaction for early detection of HIV infection in infants born to HIV antibody positive women.
- Int Conf AIDS. 1989 Jun 4-9;5:324 (abstract no. T.B.P.227). Unique Identifier : AIDSLINE ICA5/00157389
- Weintrub P; Ulrich P; Edwards J; Rumsey C; Vyas G; Cowan M; University of California, San Francisco, California, USA
- OBJECTIVE: To determine the applicability of polymerase chain reaction (PCR) for early diagnosis of HIV infection in high-risk infants. METHODS: All infants referred for prospective evaluation who were less than or equal to 3 months of age and born to HIV antibody positive women were studied. For PCR, amplifications u
- HIV p24 antigen assay as a diagnostic/prognostic test in pediatric HIV infection.
- Int Conf AIDS. 1989 Jun 4-9;5:325 (abstract no. T.B.P.228). Unique Identifier : AIDSLINE ICA5/00157489
- Silva TJ; Olson B; Simpson BJ; Andiman WA; Yale University School of Medicine, New Haven, CT, USA
- OBJECTIVE: To learn if HIV p24 antigen (Ag) detection tests can be used to diagnose infection in children or to select mothers at risk of transmitting infection. METHODS: We examined sera from a group of children born to HIV seropositive (HIV+) women as part of an ongoing prospective study of pediatric AIDS. We used a
- Sequential in parallel study of HIV infected mothers and their children since the neonatal period age.
- Int Conf AIDS. 1989 Jun 4-9;5:325 (abstract no. T.B.P.229). Unique Identifier : AIDSLINE ICA5/00157589
- Perez Alvarez L; Gurbindo MD; Munoz L; Hernandez-Sampelayo T; Varela JM; Garcia A; Instituto de Salud Carlos III; Unidad de SIDA. Madrid. Spain
- OBJECTIVES: Sequential follow up of HIV antibodies in mother-child pairs since birth and the analysis of the evolution of the bands against the different viral proteins by WB technique. - Study of the potential usefulness of the P-24 Ag analysis as suggestive marker of neonatal infection. - Confirm the existence of HI
- Comparison of the ortho HIV recombinant antigen neutralization assay and Dupont Western blot for confirmation of ELISA reactive sera from children.
- Int Conf AIDS. 1989 Jun 4-9;5:325 (abstract no. T.B.P.230). Unique Identifier : AIDSLINE ICA5/00157689
- Frost A; Mohla C; Luban N; Campos J; George Washington University Hospital, Washington, DC, USA
- OBJECTIVE: To compare the performance of the HIV Recombinant Antigen Neutralization Assay (RANA) (Ortho Diagnostic Systems, Raritan, NJ, USA) and the HIV Western blot Kit (WB) (DuPont Company, Wilmington, DE, USA) as confirmatory tests of HIV ELISA repeatedly reactive sera from high-risk children. METHODS: RANA uses a
- A novel HIV 1 EIA detects IgG and IgM antibodies in adults and neonates.
- Int Conf AIDS. 1989 Jun 4-9;5:325 (abstract no. T.B.P.231). Unique Identifier : AIDSLINE ICA5/00157789
- Baccard-Longere M; Blanc S; Genoulaz O; Giroud M; Seigneurin JM; Department of virology, A. Michallon Hospital, BP217 X, 38043; Grenoble Cedex, France
- OBJECTIVE: To study the utility of the Wellcozyme HIV Recombinant EIA in HIV diagnosis, and in particular its ability to detect IgM antibodies in infants. METHODS: The EIA was initially evaluated on 4000 sera and 500 positive samples, including 12 sera from individuals at the beginning of sero-conversion. IgM antibodi
- IgM may be directed to conformational epitopes early in seroconversion to HIV.
- Int Conf AIDS. 1989 Jun 4-9;5:325 (abstract no. T.B.P.232). Unique Identifier : AIDSLINE ICA5/00157889
- Gregg R; Smith G; Mayner R; Pollock L; Epstein JS; FDA, Bethesda, MD, USA
- OBJECTIVE: To determine if the apparent insensitivity of a whole virus immunoblot (WB) to early anti-HIV IgM in seroconversion series is a function of conformation or mass of epitopes available in that format. METHODS: Anti-HIV detection by WB (DuPont) and a recombinant gp160, p24 immunoblot (rBlot) were compared usin
- Hypergammaglobulinemia and hypogammaglobulinemia as manifestations of HIV disease in perinatally infected children.
- Int Conf AIDS. 1989 Jun 4-9;5:325 (abstract no. T.B.P.233). Unique Identifier : AIDSLINE ICA5/00157989
- Calvelli T; Steinhauer E; Pathak R; Davydov V; Bernstein L; Rubinstein A; Albert Einstein College of Medicine, Bronx, New York, USA
- OBJECTIVE: Diagnosis of HIV infection in children born to HIV positive mothers can be complicated as a result of infant B cell dysfunction even after disappearance of maternal antibody. In our experience, 8% of children presenting with symptomatology consistent with HIV infection show negative or equivocal ELISAs and
- Association between plasma human immunodeficiency virus type (HIV) viremia and clinical class of pediatric HIV infection.
- Int Conf AIDS. 1989 Jun 4-9;5:326 (abstract no. T.B.P.234). Unique Identifier : AIDSLINE ICA5/00158089
- Burchett S; Coombs R; Chaloupka K; Stamateou J; Wilson C; Corey L; University of Washington, Seattle, WA, USA
- OBJECTIVE: To develop sensitive virologic markers predictive of asymptomatic and symptomatic pediatric HIV infection. METHODS: Sequentially obtained samples from 12 HIV infected children as they progressed from CDC classification P1 to P2 and from 15 PO children were analyzed. Plasma or peripheral blood mononuclear ce
- Detection of HIV sequences in children born to seropositive mothers.
- Int Conf AIDS. 1989 Jun 4-9;5:326 (abstract no. T.B.P.235). Unique Identifier : AIDSLINE ICA5/00158189
- Borghi V; Selleri L; Lami G; Frigieri G; De Rienzo B; Torelli G; Department of Infectious Diseases, University of Modena, Modena,; Italy
- Purpose: Early detection of HIV infection in children born to seropositive mothers is now possible utilizing the polymerase chain reaction (PCR). METHODS: PCR was performed on DNA extracted from PBMCs of children born to seropositive mothers as described by Saiki. Using the SK 68 - SK 69 primers and the SK 70 probe, h
- Lymphokine and immunoglobulin production in vitro in neonates and infants with human immunodeficiency virus (HIV) infection.
- Int Conf AIDS. 1989 Jun 4-9;5:326 (abstract no. T.B.P.236). Unique Identifier : AIDSLINE ICA5/00158289
- Prieto C; Hanson IC; Hansen TN; Shearer WT; Baylor College of Medicine, Texas Children's Hospital, Houston,; TX, USA
- OBJECTIVE: To assess early immune parameters in HIV+ neonates and infants. METHODS: Interleukin-2 ( IL-2 ) was measured using an IL-2 dependent cell line (CTLL) after stimulation with PHA and augmentation with recombinant IL-2 in placental (Con 1) and infant (Con 2) cont
- Early detection of HIV-1 seroconversion in infants of seropositive mothers using serial dilutions in Western blotting.
- Int Conf AIDS. 1989 Jun 4-9;5:326 (abstract no. T.B.P.237). Unique Identifier : AIDSLINE ICA5/00158389
- Barnes S; Alexander S; Young M; Olopoenia L; Manak M; Frederick W; Howard University Hospital, Washington, DC, USA
- OBJECTIVE: To determine if serial dilutions in Western blot (WB) assay can distinguish HIV-1 seroconversion from passively transferred maternal antibody (Ab) in infants born to seropositive mothers. METHODS: Sequential serum samples collected at 3-month intervals on 17 male and 9 female infants were tested by standard
- Detection of secretory antibodies to HIV in neonates.
- Int Conf AIDS. 1989 Jun 4-9;5:326 (abstract no. T.B.P.238). Unique Identifier : AIDSLINE ICA5/00158489
- Archibald D; Nair P; Hines S; Davis E; Johnson J; University of Maryland at Baltimore, Baltimore, MD, USA
- Viral-specific, non-maternally derived secretory IgA (sIgA) antibodies have been demonstrated soon after birth in certain infections. SIgA to HIV antigens has been detected in infected adults. We collected serum and saliva from 21 children (ages 2 to 48 months) born to women at risk for HIV infection to investigate th
- Anemia and hypergammaglobulinemia in infants with perinatal HIV infection.
- Int Conf AIDS. 1989 Jun 4-9;5:326 (abstract no. T.B.P.239). Unique Identifier : AIDSLINE ICA5/00158589
- Welsh G; Hutton N; Modlin J; Department of Pediatrics, Johns Hopkins University School of; Medicine, Baltimore, Maryland, USA
- OBJECTIVE: To determine whether hematologic abnormalities or hypergammaglobulinemia are early indicators of HIV infection in infants born to HIV infected mothers. METHODS: Complete blood counts and immunoglobulin concentrations were obtained from 20 five to nine month old infants born to HIV infected mothers and who w
- ELISA (E) and Western blot (WB) patterns and a possible marker of seroreversion (SR) in infants born to seropositive (SP) women.
- Int Conf AIDS. 1989 Jun 4-9;5:327 (abstract no. T.B.P.240). Unique Identifier : AIDSLINE ICA5/00158689
- Mendez H; Holman S; Stevens R; Wethers J; Minkoff H; Landesman S; SUNY-HSCB, Brooklyn, NY, USA
- OBJECTIVE: To describe HIV serological responses and to identify predictors of infection or SR in infants born to SP mothers. METHODS: Pre and post-partum maternal sera, and infant sera collected at birth and at 3 months intervals, were frozen and later tested by E (Dupont) and WB (Organon-Teknika) against known contr
- Sequential Western blot patterns in confirmed HIV seropositive infants.
- Int Conf AIDS. 1989 Jun 4-9;5:327 (abstract no. T.B.P.241). Unique Identifier : AIDSLINE ICA5/00158789
- Luban NL; Criss VC; Joseph S; Mohla C; Campos JM; Children's Hospital National Medical Center, George Washington; University School of Medicine, Washington, DC, USA
- OBJECTIVE: To follow Western blot patterns over time in confirmed HIV seropositive infants and compare loss of specific bands with the Centers for Disease Control classification of disease. METHODS: One hundred eighty-five serial serum specimens were collected at approximate 3 month intervals from 37 confirmed seropos
- Evaluation of the Western blot IgM technique specificity.
- Int Conf AIDS. 1989 Jun 4-9;5:327 (abstract no. T.B.P.242). Unique Identifier : AIDSLINE ICA5/00158889
- Gayet-Mengelle C; Rousseau A; Puel J; Laboratoire de Virologie, CHU Purpan, Toulouse, France
- OBJECTIVE: Evaluation of the Western blot IgM technique specificity. METHODS: During the virological screening of seropositive intravenous drug abusers women (N=67) and infants born to seropositive mothers (N=20) we investigated the IgM status by the Western blot assay (Du Pont HTLV-III Western blot IgM). The test was
- Monitoring of HIV antibody profiles by RIPA as a means of diagnosing infection in infants.
- Int Conf AIDS. 1989 Jun 4-9;5:327 (abstract no. T.B.P.243). Unique Identifier : AIDSLINE ICA5/00158989
- Fauvel M; Samson J; Delage G; Boucher M; Lapointe N; Laboratoire de sante publique du Quebec, Montreal, Canada
- OBJECTIVE: In an ongoing prospective study of HIV perinatal infection, radio-immunoprecipitation assay (RIPA) was evaluated for its ability to differentiate de novo synthesis from passively transferred antibody (Ab). RIPA was also compared with virus isolation and HIV antigen (Ag) detection for early diagnosis. METHOD
- Early diagnosis of HIV-infection in children born to seropositive mothers: critical evaluation of new diagnostic approaches.
- Int Conf AIDS. 1989 Jun 4-9;5:327 (abstract no. T.B.P.244). Unique Identifier : AIDSLINE ICA5/00159089
- De Rossi A; Amadori A; Giaquinto C; Del Mistro A; Mammano F; Zacchello F; Chieco-Bianchi L; Institute of Oncology, University of Padova, Padova, Italy
- OBJECTIVE: Develop a protocol for early diagnosis in children born to HIV seropositive mothers. Correlation between diagnostic results and HIV infection status. METHODS: Children born to seropositive mothers were studied at birth and/or in the first months of life for the following parameters: 1) in vitro production o
- [Significance of systematic culturing of HIV in infants born of infected mothers]
- Int Conf AIDS. 1989 Jun 4-9;5:327 (abstract no. T.B.P.245). Unique Identifier : AIDSLINE ICA5/00159189
- Fleury HJ; Delord B; Douard D; Perel Y; Micheau M; Contraires B; Laboratoire de Virologie, CHR de Bordeaux et Universite de; Bordeaux II, Bordeaux, France
- Infusion of anti p24 antibody rich plasma in two children with persistent HIV antigenaemia - a pilot study.
- Int Conf AIDS. 1989 Jun 4-9;5:328 (abstract no. T.B.P.246). Unique Identifier : AIDSLINE ICA5/00159289
- Hague R; Yap Pl; Mok JY; Jackson GG; Hargreaves FD; Coutts NA; City Hospital, Edinburgh, United Kingdom
- OBJECTIVES: To study the clinical and laboratory sequelae of passive immunotherapy with plasma rich in anti p24 antibody on 2 children with persistent HIV core antigenaemia and seronegative for anti p24 antibody. METHODS: Plasma was harvested as previously described (Lancet 1988 ii647-652). The 2 children aged 5 and 4
- Dideoxycytidine (DDC) alone and in combination with AZT for children with symptomatic HIV infection. A phase I evaluation.
- Int Conf AIDS. 1989 Jun 4-9;5:328 (abstract no. T.B.P.247). Unique Identifier : AIDSLINE ICA5/00159389
- Pizzo PA; Einloth M; Butler K; Eddy J; Meer J; Falloon J; Pediatric Branch, National Cancer Institute, Bethesda, MD, USA
- OBJECTIVE: An agent that inhibits HIV replication without bone marrow suppression would be an important addition to the antiretroviral armamentarium. ddC , a dideoxynucleoside, like AZT
- The effects of encephalopathy and AZT treatment on the social and emotional behavior of pediatric AIDS patients.
- Int Conf AIDS. 1989 Jun 4-9;5:328 (abstract no. T.B.P.248). Unique Identifier : AIDSLINE ICA5/00159489
- Moss H; Wolters P; Eddy J; Weiner J; Pizzo L; Brouwers P; Pediatric Branch, National Cancer Institute, NIH, Bethesda, MD,; USA
- Estimates are that encephalopathy occurs in as many as 80% of pediatric AIDS patients. Evidence of improved CNS functions appears to be a sensitive indicator of the efficacy of pharmacological treatment. Therefore, it is important to further develop objective and systematic methods for monitoring behaviors reflective
- Elevated hepatic transaminases are not associated with increased Zidovudine toxicity in children with congenitally acquired HIV-1 infection.
- Int Conf AIDS. 1989 Jun 4-9;5:328 (abstract no. T.B.P.249). Unique Identifier : AIDSLINE ICA5/00159589
- Martin SR; LeMay MD; McIntosh K; Winter HS; Children's Hospital, Harvard University, Boston, MA, USA
- Zidovudine ( AZT ) has been implicated as the cause of acute hepatitis in some adults with HIV-1 infection. In addition, hepatic dysfunction may potentiate AZT bone-marrow toxicity by altering the metabolism of the drug. Children with elevated transamin
- Long-term treatment of symptomatic HIV-infection in children with Zidovudine.
- Int Conf AIDS. 1989 Jun 4-9;5:328 (abstract no. T.B.P.250). Unique Identifier : AIDSLINE ICA5/00159689
- Vocks M; Wintergerst U; Sauer S; Kreuz W; Wahn V; Rosendahl C; Koch S; Haas S; Debatin KM; Kynast I; et al; Dept. of Pediatrics, Univ. Berlin, FRG
- OBJECTIVE: To evaluate clinical, immunological and virological effects of long-term therapy in children with Zidovudine (ZDV). METHODS: 24 patients (pts) with AIDS ranging in age from 1-20 years have been treated with ZDV orally in a dosage of 3.5 mg/kg (12 pts) every 6 hours for meanly 44 weeks (4 pts 5 mg/kg; 2 pts
- Chorioretinitis responding to AZT therapy in an infant with AIDS.
- Int Conf AIDS. 1989 Jun 4-9;5:328 (abstract no. T.B.P.251). Unique Identifier : AIDSLINE ICA5/00159789
- Jonckheer T; Pierre C; de Seliys A; Moens E; Taelman H; Piot P; Institute of Tropical Medicine, Antwerp, Belgium
- INTRODUCTION: Cytomegalovirus ( CMV ) chorioretinitis is exceptionally reported in children with AIDS (2 cases mentioned). In adults CMV chorioretinitis is known to respond only to Ganciclovir or Foscarnet therapy. CASE REPORT: A six months old boy of African orig
- AZT therapy in HIV infected children.
- Int Conf AIDS. 1989 Jun 4-9;5:329 (abstract no. T.B.P.252). Unique Identifier : AIDSLINE ICA5/00159889
- Terragna A; De Maria A; Ciravegna B; Loy A; Forni F; Ferrazin A; 1 C1 Mal Infettive Istituto G. Gaslini Genova, Italy
- 12 children (6 males, 6 females) aged 4 months to 12 years, with HIV infection in class P1 (1 case) or P2 (11 cases) (CDC 1987) were treated with Zidovudine (20 to 28 mg/kg/d) every six hours for a mean of six months (range 2-6 months). Out of the study patient 12/12 were HIVp24Ag positive, 7/12 virus culture positive
- Zidovudine treatment in adolescent hemophiliac children with HIV infection.
- Int Conf AIDS. 1989 Jun 4-9;5:329 (abstract no. T.B.P.253). Unique Identifier : AIDSLINE ICA5/00159989
- Knutsen AP; Bouhasin JD; Gioia K; Mueller KB; St. Louis University Medical Center, St. Louis, MO, USA
- Nine hemophilia children with HIV infection, mean age of 13.8-years-old (range 7.6 to 18.1 years), were treated with Zidovudine (azidothymidine; AZT ), dose 115+/-14 mg/M2/dose four times daily orally for 9.9+/-3.6 months. Three children had acquired i
- Disease progression and effect of Zidovudine (AZT) in pediatric AIDS.
- Int Conf AIDS. 1989 Jun 4-9;5:329 (abstract no. T.B.P.254). Unique Identifier : AIDSLINE ICA5/00160089
- Gupta A; Ravipati M; Slade H; Leombruno C; Marecki M; Pahwa S; Dept. of Pediatrics, North Shore University Hospital, Cornell; University Medical College, Manhasset, NY, USA
- OBJECTIVE: To evaluate infants and children with presumed or established HIV infection and influence of AZT treatment. METHODS: 46 cases, age range 1 mo. to 8 years at presentation, of whom 32 had P1/P2 disease and 14 were in the PO category were eval
- Our experience in treatment with Zidovudine in children.
- Int Conf AIDS. 1989 Jun 4-9;5:329 (abstract no. T.B.P.255). Unique Identifier : AIDSLINE ICA5/00160189
- Mellado MJ; Cilleruelo MJ; Garcia M; Villota J; Perez ML; Fontelos PM; Instituto Carlos III. Serv. Pediatria. Madrid. Spain
- OBJECTIVE/METHODS: In October 87, we began a prospective study to evaluate the effectiveness of Zidovudine (ZDV) in the treatment of children suffering from AIDS. Selection parameters were: 1) Children with viremia or HIV antibodies and symptomatic infection according to class P2 of CDC for pediatric AIDS. 2) To be ol
- Selenium deficiency and cardiomyopathy in malnourished pediatric AIDS patients.
- Int Conf AIDS. 1989 Jun 4-9;5:329 (abstract no. T.B.P.256). Unique Identifier : AIDSLINE ICA5/00160289
- Kavanaugh-McHugh A; Rowe S; Benjamin Y; Hutton N; Modlin J; Ruff A; The Johns Hopkins Hospital, Baltimore, MD, USA
- OBJECTIVE: To examine the relationship between selenium deficiency and cardiomyopathy in pediatric AIDS patients. METHODS: Echocardiograms and serum selenium values were obtained on 9 pediatric patients undergoing therapy with azidothymidine for symptomatic HIV disease. Cardiomyopathy was defined as ejection fraction
- Clinical and immunological course of HIV-infection in hemophiliac and perinatally infected children prophylactically treated with immunoglobulins containing high titers of anti-CMV, anti-EBV and anti-HIV and timing of azidothymidine indication. A prospective longitudinal study of 61 children.
- Int Conf AIDS. 1989 Jun 4-9;5:329 (abstract no. T.B.P.257). Unique Identifier : AIDSLINE ICA5/00160389
- Kreuz W; Ebener U; Wegerich B; Gungor T; Haas S; Enenkel S; Debatin KM; Rehmet S; Krackhardt B; Kynast I; et al; Klinikum der J.W. Goethe-Universitat, Frankfurt am Main, FRG
- In our clinic we care for 61 children consisting of 10 HIV-infected hemophiliacs or von Willebrand patients (up to 19 years) and 51 born to HIV-positive mothers (up to 6,5 years). 24 children are classified as P 1 and P2, 6 are classified as P O according to CDC-criteria, 31 were initially P O and considered not to be
- Experience with central venous catheters in pediatric AIDS.
- Int Conf AIDS. 1989 Jun 4-9;5:330 (abstract no. T.B.P.258). Unique Identifier : AIDSLINE ICA5/00160489
- Futterman D; Connor E; Boland M; Oleske J; Children's Hospital of NJ & UMD-NJ Medical School, Newark, New; Jersey, USA
- OBJECTIVE: Children with AIDS are at high risk for infection and malnutrition, frequently requiring prolonged venous access for antibiotics and nutritional support. We undertook this study to determine the course and complication rate of central venous catheters (Broviacs) when used in a pediatric AIDS population. MET
- Neoplastic diseases in children with AIDS.
- Int Conf AIDS. 1989 Jun 4-9;5:330 (abstract no. T.B.P.259). Unique Identifier : AIDSLINE ICA5/00160589
- Joshi VV; Connor EM; DiCarlo F; Epstein LG; Oleske JM; Departments of Clinical Pathology and Pediatrics, East Carolina; University School of Medicine, Greenville, NC, USA
- OBJECTIVE: To describe the incidence and types of neoplastic diseases (ND) in children with AIDS. METHODS: Biopsy (35 cases) and/or autopsy (18 cases) material from 102 HIV infected children. RESULTS: Seven cases showed ND. The risk factor in five of the cases was parental IV drug use. In 2 cases HIV was acquired via
- Safety and efficacy of central venous catheters in pediatric AIDS patients.
- Int Conf AIDS. 1989 Jun 4-9;5:330 (abstract no. T.B.P.260). Unique Identifier : AIDSLINE ICA5/00160689
- Gleason-Morgan D; Church J; Bagnall H; Atkinson J; Childrens Hospital of Los Angeles & University of Southern; California School of Medicine, Los Angeles, California, USA
- OBJECTIVE: To determine the safety and efficacy of central venous catheters (CVCs) in pediatric AIDS patients (pts). METHOD: A retrospective chart review of children with CDC-defined AIDS (P2D) who had CVCs placed due to inadequate venous access. RESULTS: The medical records of 11 pts (7 male, 4 female), ages 3 mos to
- HIV infection (HIV) in patients (pts) treated for leukemia or solid tumor, a pediatric oncology group (POG) study.
- Int Conf AIDS. 1989 Jun 4-9;5:330 (abstract no. T.B.P.261). Unique Identifier : AIDSLINE ICA5/00160789
- Baruchel S; Clavel L; Toledano S; McGill University, Montreal, Quebec, Canada
- OBJECTIVE AND METHODS: A questionnaire was sent to POG institutions to enquire about (a) the number of pts infected by HIV among children treated for leukemia or solid tumors; (b) the impact of chemotherapy on the natural history of HIV; (c) the interaction between HIV and cancer; (d) and institutional attitudes regar
- Very late onset of group B streptococcal sepsis in infants with HIV infection.
- Int Conf AIDS. 1989 Jun 4-9;5:330 (abstract no. T.B.P.262). Unique Identifier : AIDSLINE ICA5/00160889
- Di John D; Johnson JP; Lawrence R; Schieken LS; Rennels MB; New York University Medical Center-Bellevue Hospital Center, New; York, NY, USA
- OBJECTIVE: To describe characteristics of Group B streptococcal (GBS) disease in HIV infected children. METHODS: GBS disease was identified in 3/200 (1.5%) of HIV infected children diagnosed at the University of Maryland and NYU Medical Center. Charts were reviewed to describe clinical features, course, and outcome of
- Diarrhea and its consequences in HIV-infected children.
- Int Conf AIDS. 1989 Jun 4-9;5:330 (abstract no. T.B.P.263). Unique Identifier : AIDSLINE ICA5/00160989
- Kotloff K; Johnson JP; Nair P; Losonsky GA; Young A; Morris JG; University of Maryland School of Medicine, Baltimore, Maryland,; USA
- OBJECTIVE: To determine the incidence, etiology, and sequelae of diarrhea in children with symptomatic HIV infection. METHODS: Children with AIDS and ARC (n=16) were prospectively enrolled and serially evaluated. When a physician visit was made for diarrhea, a whole stool or rectal swab was examined for bacterial ente
- Burkitt lymphoma in an HIV-infected child.
- Int Conf AIDS. 1989 Jun 4-9;5:331 (abstract no. T.B.P.264). Unique Identifier : AIDSLINE ICA5/00161089
- Caselli D; Arico M; Deicas A; Michelone G; Maccabruni A; Lanzarini P; Dept. Pediatrics, University of Pavia, Italy
- HIV infection in children is infrequently complicated with malignancies: Kaposi sarcoma (less than 5%), a few cases of malignant brain lymphoma, one case of Burkitt lymphoma (BL) were reported. We describe BL in a 3-year-old white female, born to drug abuser seropositive mother, admitted because of fever, anorexia, in
- Chronic mucocutaneous candidiasis in pediatric AIDS.
- Int Conf AIDS. 1989 Jun 4-9;5:331 (abstract no. T.B.P.265). Unique Identifier : AIDSLINE ICA5/00161189
- Iosub S; Bamji M; Stone RK; Gromisch DS; Wasserman E; New York Medical College, New York, USA
- OBJECTIVE: To compare the incidence of persistent mucocutaneous candidiasis in patients diagnosed as AIDS in the first year of life (group I) vs those diagnosed later (group II). METHODS: The study was performed at two public hospitals in New York City on sixty two patients with perinatal HIV infection admitted from 1
- Opportunistic infections and mortality in an urban pediatric population infected with human immunodeficiency virus (HIV).
- Int Conf AIDS. 1989 Jun 4-9;5:331 (abstract no. T.B.P.266). Unique Identifier : AIDSLINE ICA5/00161289
- Hanson IC; Rosenblatt HM; Shearer WT; Baylor College of Medicine and Texas Children's Hospital,; Houston, Texas, USA
- OBJECTIVE: To define opportunistic infections (OI) that were most prevalent and linked with the highest mortality rate in an urban pediatric population. METHODS: 73 pediatric HIV patients followed up to 7 years (mean 2 years) were reviewed for evidence of OI (Centers for Disease Control, stage D-1). RESULTS: As in the
- Spectrum of infections identified at autopsy in pediatric AIDS.
- Int Conf AIDS. 1989 Jun 4-9;5:331 (abstract no. T.B.P.267). Unique Identifier : AIDSLINE ICA5/00161389
- Ross LA; Wong VK; Gomperts ED; Ricalde AL; Church JA; Childrens Hospital of Los Angeles and U.S.C. School of Medicine,; Los Angeles, California, USA
- OBJECTIVE: To identify the spectrum and sites of infection in children dying of AIDS. METHOD: 33 children with full-blown AIDS have been followed at Childrens Hospital of Los Angeles; 22 have expired; 12 postmortem examinations revealed the following: TABULAR DATA, SEE ABSTRACT VOLUME. CONCLUSION: Multiple infectious
- Hematologic effects and outcome of Zidovudine (AZT) therapy.
- Int Conf AIDS. 1989 Jun 4-9;5:331 (abstract no. T.B.P.268). Unique Identifier : AIDSLINE ICA5/00161489
- Schlech W; Marrier G; Johnston B; Dalhousie University Faculty of Medicine, Halifax, Nova Scotia,; Canada
- OBJECTIVE: To describe the hematologic effects and outcomes of Zidovudine ( AZT ) therapy in CDC group III and group IV HIV-infected patients (pts). METHODS: 20 AIDS and 14 group IVa and group III (n=34) pts were enrolled in the open trial of AZT and fo
- Thrombocytopenia in HIV infection.
- Int Conf AIDS. 1989 Jun 4-9;5:331 (abstract no. T.B.P.269). Unique Identifier : AIDSLINE ICA5/00161589
- Sacchi G; Zorzi F; Bonetti M; Falchetti M; Stellini R; Scalzini A; 1st Service of Pathology, Spedali Civili Brescia, Italy
- OBJECTIVE: To describe the incidence of thrombocytopenia in HIV positive pts., to assess the bone marrow lesions and the prognostic significance of thrombocytopenia in the AIDS evolution. METHODS: On Dec. 31, 1988, eighty-eight cases of thrombocytopenia were observed within a population of about 1000 HIV positive pts.
- Platelet production in HIV infection - evidence for a compensated thrombolytic state enhanced by AZT.
- Int Conf AIDS. 1989 Jun 4-9;5:332 (abstract no. T.B.P.270). Unique Identifier : AIDSLINE ICA5/00161689
- Ballem P; Belzberg A; Chambers H; Spruston B; Department of Medicine. St. Paul's Hospital, Vancouver, B.C.,; Canada
- Thrombocytopenia (decreased plt) is common in HIV infection, often due to marrow suppression 2 degrees infection, drugs or infiltration. In the absence of these, some patients have decreased plts. associated with increased plt.-associated IgG (HIV-1TP). Kinetic studies performed with 111-Indium-labelled plts. in 12 pa
- Effects of long term Zidovudine on platelet count.
- Int Conf AIDS. 1989 Jun 4-9;5:332 (abstract no. T.B.P.271). Unique Identifier : AIDSLINE ICA5/00161789
- Flegg PJ; Jones ME; MacCallum LR; Williams KG; Cook MK; Brettle RP; ID Unit, City Hospital, Haematology, Edinburgh, United Kingdom
- OBJECTIVE: To assess the long term platelet response of Zidovudine following reports of short term beneficial effects in HIV related immune thrombocytopenia (ITP). METHODS: 38 patients received Zidovudine in standard doses with adjustments or stoppage for toxicity for greater than 12 weeks (14 with AIDS and 24 others)
- Response to splenectomy for severe HIV-related thrombocytopenia in 10 drug abusers and pathological features of the spleens.
- Int Conf AIDS. 1989 Jun 4-9;5:332 (abstract no. T.B.P.272). Unique Identifier : AIDSLINE ICA5/00161889
- Landonio G; de Cataldo F; Gargantini L; Nosari AM; Costantini M; Gambacorta M; Department of Hemathology Niguarda Ca'Granda Hospital, Milan,; Italy
- OBJECTIVE: To evaluate the response to splenectomy for severe HIV-related thrombocytopenia in a medium term follow-up and the pathological features of the spleens. METHODS: 10 patients (all intravenous drug abusers -IVDAs-) with severe HIV-related thrombocytopenia (PLT less than 5x10 (9)/L), who failed to respond to s
- HIV-related immune thrombocytopenia: follow up and treatment of 132 patients.
- Int Conf AIDS. 1989 Jun 4-9;5:332 (abstract no. T.B.P.273). Unique Identifier : AIDSLINE ICA5/00161989
- Oksenhendler E; Archambault MP; Delfraissy JF; Bierling P; Peynet J; SelIgMann M; Groupe d'etude des cytopenies liees au HIV - Paris - France
- OBJECTIVE: Longitudinal study of HIV infected patients with thrombocytopenia (platelets less than 50 x 10(9)/1). Patients at initial evaluation: 132 patients (IV drug addicts: 56; homosexual men: 36, hemophiliacs: 23; others: 17). 56% belonged to CDC group II, 30% to group III and 14% to group IV, none had AIDS. CD4 c
- HIV - associated thrombocytopenia (HTP), platelet - associated immunoglobulin (PAI) and Zidovudine.
- Int Conf AIDS. 1989 Jun 4-9;5:332 (abstract no. T.B.P.274). Unique Identifier : AIDSLINE ICA5/00162089
- Carcaba V; Carton JA; Vicente P; Maradona JA; SanRoman F; Llorente R; Garcia Z; Hospital Universitario de Oviedo. Spain
- OBJECTIVE: To establish the incidence, permanence and pathogenic role of PAI in HTP treated with Zidovudine, and in non-thrombocytopenic HIV-infected patients. METHODS: PAI was determined by platelet suspension immunofluorescence test to 23 HIV-infected patients with normal platelet count and 8 HTP (less than 100 x 10
- Therapy of HIV associated thrombocytopenia.
- Int Conf AIDS. 1989 Jun 4-9;5:332 (abstract no. T.B.P.275). Unique Identifier : AIDSLINE ICA5/00162189
- Lim SG; Lee CA; Kernoff PB; Haemophilia Centre and Haemostasis Unit, Academic department of; Haematology, Royal Free Hospital, London, United Kingdom
- OBJECTIVE: To assess the therapy of HIV associated thrombocytopenia. METHODS: A retrospective analysis of 111 HIV positive haemophiliacs showed 7 with thrombocytopenia less than 50 x 10(9)/L. 4 patients were CDC II, 1 was CDC III and 2 were CDC IV. Their mean age was 26 years (range:5-38), and they had been HIV positi
- Lack of efficacy of on-line column-A-adsorption in treatment of HIV-associated ITP.
- Int Conf AIDS. 1989 Jun 4-9;5:333 (abstract no. T.B.P.276). Unique Identifier : AIDSLINE ICA5/00162289
- Scolaro MJ; Kennedy P; Los Angeles Oncologic Institute, St. Vincent Medical Center, Los; Angeles, California 90057, USA
- OBJECTIVE: To determine the clinical efficacy of on-line CAA in restoring normal platelet count in patients with HIV-related ITP. Previous studies have demonstrated the value of off-line CAA in treatment of HIV-1TP. METHOD: We treated 7 patients with ITP (platelet count range 18,000/cu mm to 85,000/cu mm, mean 39,000/
- [Effectiveness of zidovudine in a low dose in treating thrombopenia related to HIV virus]
- Int Conf AIDS. 1989 Jun 4-9;5:333 (abstract no. T.B.P.277). Unique Identifier : AIDSLINE ICA5/00162389
- Routy JP; Blanc AP; Garabedian C; Maurice C; David M; Jolio Y; Hopital Cezanne 13616 Aix-en-Provence France
- Combined steroid-Zidovudine treatment of severe thrombocytopenia associated with HIV infection.
- Int Conf AIDS. 1989 Jun 4-9;5:333 (abstract no. T.B.P.278). Unique Identifier : AIDSLINE ICA5/00162489
- Arrizabalaga J; Iribarren JA; Santamaria JM; Zubero Z; Garde C; Zulaica D; Hospital Nuestra Senora de Aranzazu, San Sebastian, and; Hospital Civil de Basurto, Bilbao, Spain
- OBJECTIVE: Assessment of the efficacy of combined steroid-Zidovudine treatment in patients with severe thrombocytopenia and HIV infection. METHODS: Since June 1988 a therapeutic protocol of steroids and Zidovudine has been in effect for patients with HIV infection and severe thrombocytopenia (platelets under 20.10(9)/
- Phase II study of alpha 2A interferon (INF) associated with AZT in patients (pts) with AIDS related Kaposi's sarcoma.
- Int Conf AIDS. 1989 Jun 4-9;5:333 (abstract no. T.B.P.279). Unique Identifier : AIDSLINE ICA5/00162589
- Gonzalez-Canali G; Navarro-Carola E; De Gramont A; Demuynck B; Louvet C; Krulik M; Hopital Saint-Antoine - Paris - France
- INF is the standard therapy for AIDS-KS and AZT has demonstrated antiviral activity in AIDS. 15 pts with AIDS-KS received alpha 2A INF (18 MU daily IM) associated with AZT 1200 mg orally (200 mg every 4 hs) daily. All pts had biopsy proven KS with a m
- Treatment of lymphomas (NHL) associated with human immunodeficiency virus (HIV).
- Int Conf AIDS. 1989 Jun 4-9;5:333 (abstract no. T.B.P.280). Unique Identifier : AIDSLINE ICA5/00162689
- Gisselbrecht C; Oksenhendler E; Farcet JP; Dombret H; Coiffier B; Raphael M; Paris, Creteil, Lyon, Nice, France. Supported by INSERM
- NHL-HIV have a poor prognosis related to both lymphoma and associated opportunistic infections (OI). In order to evaluate the place of intensive chemotherapy in a subset of patients with NHL-HIV. Pts were stratified in 2 risk groups. Group A: no OI and performance status less than 2 (OMS); group B: performance status
- Correlation of effects of interferon-alpha in AIDS-associated Kaposi's sarcoma with serum levels and dose.
- Int Conf AIDS. 1989 Jun 4-9;5:333 (abstract no. T.B.P.281). Unique Identifier : AIDSLINE ICA5/00162789
- Sawyer L; Boone E; Zoon K; Metcalf J; Lane H; Quinnan G; Division of Virology, CBER, FDA, Bethesda, MD, USA
- OBJECTIVE: To study the relationship between the dose and blood levels of interferon-alpha (IFN) to responses to treatment of patients with Kaposi s sarcoma (KS). METHODS: We studied 37 patients with KS enrolled in studies of IFN therapy alone and in combination with Zidovudine (
- Efficacy of high dose (50 MU/M2) intravenous recombinant interferon ALFA-2-b (HD.IV.rIFN alpha 2b) in AIDS related Kaposi's sarcoma.
- Int Conf AIDS. 1989 Jun 4-9;5:334 (abstract no. T.B.P.282). Unique Identifier : AIDSLINE ICA5/00162889
- Beaucaire G; Chidiac C; Brion JP; Lacut JY; Massip P; Department of Infectious Diseases. University of Lille. France.
- OBJECTIVES: From March 1987 to December 1988, an open study was performed to assess the efficacy of HD.IV.rIFN alpha 2b that was given 5 days/week, every other week, in the treatment of AIDS related Kaposi s sarcoma (AIDS/KS). METHODS: The KS stages were ranged according to the KRIGEL classification with a special ref
- HIV-antigenemia in patients with AIDS-related Kaposi's sarcoma (KS) treated with recombinant alpha-2a interferon (IFN).
- Int Conf AIDS. 1989 Jun 4-9;5:334 (abstract no. T.B.P.283). Unique Identifier : AIDSLINE ICA5/00162989
- Rozenbaum W; Gharakhanian S; Rouzioux C; De Sahb R; Bugard M; Cardon B; Infectious Disease Unit, Rothschild Hosp.; Virology lab, Necker; Hosp.; Paris, France
- OBJECTIVE: To assess the link between HIV antigen (Ag) level and clinical response to IFN in KS. METHODS: 76 males, mean age 37.5, were treated for biopsy-proven KS with 18M units a day of IFN during a mean of 168+/-77 days. Ag was assessed before and during treatment, measured blind by the Abbott technique with conce
- Chemotherapy with or without granulocyte-marcrophage colony stimulating factor (rGM-CSF) in patients with AIDS-associated non-Hodgkin's lymphoma (NHL).
- Int Conf AIDS. 1989 Jun 4-9;5:334 (abstract no. T.B.P.284). Unique Identifier : AIDSLINE ICA5/00163089
- Kaplan LD; Kahn JO; Grossberg H; Volberding PA; Department of Medicine, San Francisco General Hospital, San; Francisco, CA, USA
- OBJECTIVE: To determine whether rGM-CSF can reduce chemotherapy-induced myelosuppression in patients with AIDS-associated NHL. METHODS: Patients were randomized to receive CHOP (Cyclophosphamide 1g/m2/d1, Doxorubicin 40mg/m2/d2, vincristine 2mg, Prednisone 100mg/m2/d1-5) with or without rGM-CSF 10-15mcg/kg subcutaneou
- Adoptive transfer of immunity to recall antigens following allogeneic bone marrow transplantation (BMT) in an AIDS patient with non-hodgkin's lymphoma (NHL).
- Int Conf AIDS. 1989 Jun 4-9;5:334 (abstract no. T.B.P.285). Unique Identifier : AIDSLINE ICA5/00163189
- Donnenberg AD; Holland HK; Burns WH; Santos GW; Saral R; The Johns Hopkins University, Baltimore, MD, USA
- OBJECTIVES: We have previously shown that transfer of donor immunity can be reproducibly achieved after allogeneic BMT by boosting the BM donor before transplant and/or the recipient on the day of BMT. The present study was conducted on a 41 yo HIV-1 culture+ man with NHL who received combined modality therapy of allo
- Carbon monoxide diffusing capacity (DLCO) as a predictor of lung function in patients receiving bleomycin for treatment of Kaposi's sarcoma.
- Int Conf AIDS. 1989 Jun 4-9;5:334 (abstract no. T.B.P.286). Unique Identifier : AIDSLINE ICA5/00163289
- Akil B; Ireland-Gill A; Espinar BE; Gill P; University of Southern California, Los Angeles, California 90033
- OBJECTIVES: The purpose of this study was to evaluate the effect of Bleomycin-containing chemotherapeutic regimens on the pulmonary function in patients with Kaposi s Sarcoma (KS) associated with AIDS. METHODS: We evaluated 19 patients who had at least two sets of Pulmonary Function Tests (PFT s) one before and after
- Regression of Kaposi's sarcoma (KS) following PROSORBA(R) column treatments.
- Int Conf AIDS. 1989 Jun 4-9;5:334 (abstract no. T.B.P.287). Unique Identifier : AIDSLINE ICA5/00163389
- Reed DE; Snyder HW; Balint JP; Jones FR; IMRE Corporation, Seattle, WA, USA
- OBJECTIVE: - To modulate immune system activity and induce regression of KS by removal of IgG and circulating immune complexes (CIC) from patient plasma. METHODS: - A clinical trial of immunoadsorption of plasma was carried out with 23 patients who had progressive KS and had received no anti-tumor or anti-viral therap
- Adverse reactions with high dose (50MU/M2) intravenous recombinant interferon ALFA 2b (HD.IV.rIFN.alpha 2b) in AIDS related Kaposi's sarcoma.
- Int Conf AIDS. 1989 Jun 4-9;5:335 (abstract no. T.B.P.288). Unique Identifier : AIDSLINE ICA5/00163489
- Beaucaire G; Mouton Y; Biron F; Lepeu G; Reynes J; Department of Infectious Diseases. University of Lille. France
- OBJECTIVES: From March 1987 to December 1988, an open study was performed to appraise the efficacy and the tolerance of HD.IV.rIFN alpha 2b, that was given 5 days/week, every other week, in the treatment of AIDS related Kaposi s sarcoma (AIDS/KS). METHODS: The 34 initially enrolled patients were all men: 25 homo- and
- High doses of interferon ALFA 2-b in Kaposi's sarcoma.
- Int Conf AIDS. 1989 Jun 4-9;5:335 (abstract no. T.B.P.289). Unique Identifier : AIDSLINE ICA5/00163589
- Ocana I; De Luis A; Ruiz I; Bejarano E; De Buen L; Martinez Vazquez JM; Department of Internal Medicine, Hospital Vall d'Hebron,; Barcelona, Spain
- OBJECTIVE: The efficacy and safety of Interferon alfa 2-b (Intron A) were evaluated in patients with AIDS related Kaposi s sarcoma (KS). METHODS: From June 1986 to December 1988, 9 patients (8 homosexual or bisexual men and 1 drug-addict woman) were included in this trial. The mean age was 32 years (20-41 Yrs). The KS
- Intralesional vinblastine (Velban) treatment of lesions of Kaposi's sarcoma.
- Int Conf AIDS. 1989 Jun 4-9;5:335 (abstract no. T.B.P.290). Unique Identifier : AIDSLINE ICA5/00163689
- Conant MA; Galzagorry G; Illeman M; University of California, San Francisco, California, USA
- OBJECTIVE: To determine effectiveness and safety of using Vinblastine (Velban) therapy intralesionally into individual lesions of Kaposi s sarcoma. METHODS: Fifteen subjects with previously diagnosed Kaposi s sarcoma and positive HIV antibody tests were entered into the study. Lesions of Kaposi s sarcoma of any cutane
- Remission of Kaposi-sarcoma by a combined therapy with interferon-beta + AZT in an AIDS patient.
- Int Conf AIDS. 1989 Jun 4-9;5:335 (abstract no. T.B.P.291). Unique Identifier : AIDSLINE ICA5/00163789
- Knechten H; Braeck F; Hem.-Onc. Institute, Aachen, FRG
- We report the case of an HIV-1-infected patient with Kaposi-Sarcoma (KS), who was treated with human fibroblast interferon-beta (IFN-beta, FIBLAFERON(R), Dr. Rentschler, Laupheim, FRG)+ AZT (RETROVIR(R), Wellcome, Burgwedel, FRG). The HIV-1-infection
- Interferon administered intralesionally in skin, conjunctiva and oral cavity lesions in patients with AIDS-related Kaposi's sarcoma.
- Int Conf AIDS. 1989 Jun 4-9;5:355 (abstract no. T.B.P.292). Unique Identifier : AIDSLINE ICA5/00163889
- Sulis E; Floris C; Sulis ML; Tedde A; Turno R; Contu L; Div. Medicina I, Osp. Oncol. A. Businco, USL 21, Cagliari,; Italy
- The efficacy of interferon (IFN) in the therapy of AIDS related Kaposi s Sarcoma (AIDS-KS) seems to be dose-dependent. The concentration of massive doses of IFN in the tumoral lesions by intralesional injection seems to be a rational approach. We have treated 9 male patients (average age 24 years, heterosexuals, drug
- Assessment of the management of Kaposi's sarcoma (KS) in AIDS patients.
- Int Conf AIDS. 1989 Jun 4-9;5:335 (abstract no. T.B.P.293). Unique Identifier : AIDSLINE ICA5/00163989
- Garcia-Polo I; Santos I; del Arco C; Fraga J; Fernandez J; Noguerado A; Hospital de la Princesa,-M. Interna, Universidad Autonoma,; Madrid-Spain
- OBJECTIVES: To assess the usefulness of Zidovudine (ZDV) and Interferon (IF) in patients with KS associated to AIDS. PATIENTS AND METHODS: 17 patients aged 24-44 years (mean 34,3), without previous opportunistic infection with histologically proven KS. 7 patients received ZDV - only (1200 mg/day) and 4 patients with m
- Comparison of ribavirin versus placebo for preventing the progression of HIV infected subjects from CDC stage III to stage IV.
- Int Conf AIDS. 1989 Jun 4-9;5:336 (abstract no. T.B.P.294). Unique Identifier : AIDSLINE ICA5/00164089
- Barcelona, Madrid, Bilbao, San Sebastian, Spain
- OBJECTIVE: To compare the efficacy of ribavirin versus placebo to prevent the progression of HIV-infected patients from CDC stage III to stage IV. METHODS: 131 HIV-infected patients (20% homosexuals, 64% drug addicts) on CDC stage III, and a CD4 cell count between 50 and 500 per mm3 were included in a double blind mul
- Dextran sulfate is poorly absorbed after oral administration.
- Int Conf AIDS. 1989 Jun 4-9;5:336 (abstract no. T.B.P.295). Unique Identifier : AIDSLINE ICA5/00164189
- Lorentsen K; Hendrix C; Collins J; Eckel R; Petty B; Lietman P; Johns Hopkins University, Baltimore, MD
- OBJECTIVE: To determine whether dextran sulfate, a synthetic analogue of heparin with anti-human immunodeficiency virus activity in vitro, is absorbed after oral administration. METHODS: Volunteers were given an 1800 mg. oral dose followed forty-eight hours later by a 225 mg. intravenous infusion of dextran sulfate. B
- Ribavirin dose escalating phase 1 trial in patients with AIDS and ARC.
- Int Conf AIDS. 1989 Jun 4-9;5:336 (abstract no. T.B.P.296). Unique Identifier : AIDSLINE ICA5/00164289
- Crumpacker C; Cotton D; Pearlstein G; Valentine F; Mills J; Spector S; Beth Israel Hospital, Boston, MA, USA
- OBJECTIVE: To carry out an increasing dose phase I trial to find maximum tolerated dose of Ribavirin (RBV). METHODS: Patients in 3 arms, 1) AIDS no previous treatment; 2) ARC; 3) AIDS, AZT failures; were enrolled in a 6 month trial of RBV 800, 1200, 1
- Phase I study of 2', 3' dideoxyinosine (ddI) given once daily to patients with AIDS or ARC.
- Int Conf AIDS. 1989 Jun 4-9;5:336 (abstract no. T.B.P.297). Unique Identifier : AIDSLINE ICA5/00164389
- Cooley T; Saunders CA; Perkins CJ; McCaffery RP; McLaren C; Liebman HA; Boston University School of Medicine, Boston, MA, USA
- OBJECTIVE: To determine maximum tolerated dose (MTD), pharmacokinetics (PK) and efficacy of iv and oral ddI given once daily. METHODS: To date, 8 patients (6 men, 2 women) with AIDS (4) or ARC (4) were treated. Plasma and urine were collected after initial iv infusion and at steady state doses of 0.8 (1), 2 (5), 3.5 (
- Evaluation of megestrol acetate treatment in AIDS.
- Int Conf AIDS. 1989 Jun 4-9;5:336 (abstract no. T.B.P.298). Unique Identifier : AIDSLINE ICA5/00164489
- Gold J; Oliver C; Albion Street (AIDS) Centre, Sydney Hospital, Sydney, Australia
- OBJECTIVE: To evaluate the components of weight gain associated with megestrol acetate therapy in cachexic males with stage IV HIV disease. METHODS: Ten males with a weight loss of 15-20% of usual weight due to late stage HIV disease were treated with megestrol acetate (80 mg, three times a day). Subjects were treated
- Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF): lack of neurological toxicity.
- Int Conf AIDS. 1989 Jun 4-9;5:336 (abstract no. T.B.P.299). Unique Identifier : AIDSLINE ICA5/00164589
- Brew BJ; Keilp JG; Sadler AE; Krown SE; Anselmo W; Birnhak L; Sidtis JJ; Price RW; Bonnem E; Memorial Sloan-Kettering Cancer Center, NY, NY, USA
- OBJECTIVE: To assess the possibility of neurological toxicity of GM-CSF in neutropenic AIDS patients without dementia . METHODS: Patients enrolled in a phase 1 trial of GM-CSF as treatment for AIDS-related neutropenia were evaluated by quantitative neurological and neuropsychologica
- Occupational therapy for people with AIDS.
- Int Conf AIDS. 1989 Jun 4-9;5:337 (abstract no. T.B.P.300). Unique Identifier : AIDSLINE ICA5/00164689
- Jacobs J; Lebowitz V; Center for Special Studies, NY, NY, USA
- OBJECTIVE: To maintain and/or improve functional independence and quality of life for HIV+/AIDS patients and their families. To be cost effective by decreasing frequency and length of hospital admissions and hours of home health care needed. METHODS: Occupational therapy as a component of Rehabilitation Medicine, assi
- Supervised physical exercise leads to psychological and immunological improvement in pre-AIDS patients.
- Int Conf AIDS. 1989 Jun 4-9;5:337 (abstract no. T.B.P.301). Unique Identifier : AIDSLINE ICA5/00164789
- Schlenzig C; Jager H; Rieder H; Hammel G; Popescu M; University of Heidelberg, Heidelberg, FRG
- OBJECTIVE: The immunological and psychological effects of therapeutically supervised physical exercise in HIV-AB positive individuals were investigated in a randomized controlled prospective study. METHODS: Twenty-eight HIV-AB positive patients were stratified according to the Walter-Reed-Staging- Classification (Stag
- Long term ribavirin treatment.
- Int Conf AIDS. 1989 Jun 4-9;5:337 (abstract no. T.B.P.302). Unique Identifier : AIDSLINE ICA5/00164889
- Banhegyi D; Lendvay J; Ujhelyi E; Fust G; Mihaly I; Varnai F; Institute for Infectious and Tropical Diseases, Postgraduate; Medical School, Budapest, Hungary
- OBJECTIVE: To evaluate clinical efficacy, safety and tolerance of long term ribavirin treatment. METHODS: Four patients /pts/ /stage III-3 stage IVA-1/ were treated with 600 mg/day ribavirin orally. Number and ratio of CD4+ and CD8+ lymphocytes, serum levels of immunoglobulin, neopterin and HIV p24 antigen were determ
- A phase I study of the safety and pharmacokinetics of soluble recombinant CD4 (rCD4) in patients with AIDS and ARC.
- Int Conf AIDS. 1989 Jun 4-9;5:337 (abstract no. T.B.P.303). Unique Identifier : AIDSLINE ICA5/00164989
- Allan JD; Kahn J; Hodges T; Sherwin S; Volberding P; Groopman J; New England Deaconess Hospital, Boston, MA, USA
- OBJECTIVE: To determine the safety and maximal tolerated dose of rCD4 and preliminary indications of antiviral effects of rCD4 in patients with AIDS & ARC. METHODS: A 2 center, phase I study with dose escalation and monitoring of the safety, pharmacokinetics, and clinical effect of rCD4 in 30 patients with AIDS or
- [Randomized trial of placebo versus high dosage acyclovir in HIV patients]
- Int Conf AIDS. 1989 Jun 4-9;5:337 (abstract no. T.B.P.304). Unique Identifier : AIDSLINE ICA5/00165089
- Chavanet P; Aho S; Mallet J; Waldner A; Buisson M; Bielefeld P; Portier H; Service des Maladies Infectieuses. Hopital du Hocage, BP1542,; 21034 Dijon, France
- [Generalized epileptic seizure after absorption of a toxic dose of zidovudine (a case report)]
- Int Conf AIDS. 1989 Jun 4-9;5:337 (abstract no. T.B.P.305). Unique Identifier : AIDSLINE ICA5/00165189
- Routy JP; Prajs E; Blanc AP; Drony S; Moriceau M; Sarrazin C; Hopital Cezanne, Aix en Provence, France
- Effective doses of AZT in HIV-1TP is associated with erythroid hypoplasia.
- Int Conf AIDS. 1989 Jun 4-9;5:338 (abstract no. T.B.P.306). Unique Identifier : AIDSLINE ICA5/00165289
- Huebsch LB; Garber G; Cameron DW; Aye MT; Department of Medicine, University of Ottawa and Ottawa General; Hospital, Ottawa, ON, Canada
- Idiopathic thrombocytopenic purpura (ITP) is not an uncommon finding in patients with HIV infection. The etiology of this thrombocytopenia remains unclear although immune complex disease has often been quoted as a contributory cause. Another possible mechanism is a defect in platelet production by HIV infected marrow
- Vitamin B 12 supplements in patients treated with Zidovudine.
- Int Conf AIDS. 1989 Jun 4-9;5:338 (abstract no. T.B.P.307). Unique Identifier : AIDSLINE ICA5/00165389
- Navarette MS; Gharakhanian S; Cardon B; Rozenbaum W; Infectious Disease Unit, Rothschild Hospital, Paris, France
- OBJECTIVE: To evaluate the efficacy of Vitamin B12 (Vit. B12) in the prevention of Zidovudine (Z) induced anemia. METHODS: AIDS or ARC patients (pts), receiving Z were randomized in 2 groups. One group was administered weekly injections of Vit. B12 (1000 mcg) as of the first week of their treatment. Both groups receiv
- Toxicity of Zidovudine (AZT) in patients with AIDS.
- Int Conf AIDS. 1989 Jun 4-9;5:338 (abstract no. T.B.P.308). Unique Identifier : AIDSLINE ICA5/00165489
- Clotet B; Gimeno JM; Jou A; Sirera G; Tor J; Dominguez M; Foz M; Infectious Diseases Unit. Hospital de Badalona Germans Trias i; Pujol, Barcelona, Catalonia, Spain
- OBJECTIVE: To report the hematologic toxicity observed in 32 AIDS patients treated with Zidovudine for a 3 month period. MATERIAL: Thirty-two AIDS patients, fulfilling the CDC criteria for AIDS, received AZT at a dosage regimen of 1200 mg/d. Hematolog
- [Prolonged corticotherapy in a dermatopolymyositis patient with HIV]
- Int Conf AIDS. 1989 Jun 4-9;5:338 (abstract no. T.B.P.309). Unique Identifier : AIDSLINE ICA5/00165589
- Roue R; Debord T; Dormont D; Vazeux R; Tisne B; Hopital Militaire Begin, 94160, Saint-Mandee
- Successful re-introduction of Zidovudine (AZT) after an allergic cutaneous reaction to AZT.
- Int Conf AIDS. 1989 Jun 4-9;5:338 (abstract no. T.B.P.310). Unique Identifier : AIDSLINE ICA5/00165689
- Mathieu-Boue A; Halfon P; Lebras P; Caquet R; CISIH, Paris Sud, France
- Allergic cutaneous reactions to AZT are uncommon and usually lead to definitive withdrawal of this drug. We report here a case of successful reintroduction schedule. A HIV seropositive 29 year old male (heterosexual exposure) with an oral hairy leucop
- Role of p24 Ag testing in patients on Zidovudine.
- Int Conf AIDS. 1989 Jun 4-9;5:339 (abstract no. T.B.P.311). Unique Identifier : AIDSLINE ICA5/00165789
- Hoy J; Chua J; Mijch A; Dimitrikakis M; Gust I; Lucas CR; Fairfield Infectious Diseases Hosp., Melbourne, Victoria,; Australia
- OBJECTIVE: To examine the role of regular measurement of serum p24 antigen (ag) in the management of HIV infected patients (pts) on Zidovudine ( AZT ). METHODS: From 1 June 1987, 95 pts (59 AIDS, and 36 ARC) have received AZT for 6-18 months, reviewed 2
- Change in beta-2 microglobulin (B2M) during Zidovudine (ZDV) therapy (RX) predicts clinical outcome.
- Int Conf AIDS. 1989 Jun 4-9;5:339 (abstract no. T.B.P.312). Unique Identifier : AIDSLINE ICA5/00165889
- Jacobson MA; Abrams D; Bacchetti P; Kocurek K; Wilber J; Moss AR; UCSF, SF General Hospital, San Francisco, CA, USA
- OBJECTIVE: Determine if changes during ZDV Rx in CD4 lymphocyte number or any of 4 serologic markers of HIV activity predict clini